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Sorting nexin 27 (SNX27) is a newly identified member of the SNX family that is 
characterized by the presence of an evolutionarily conserved Phox (PX) domain. 
SNX27 is targeted to the early endosome by the interaction of its PX domain with 
phosphatidylinositol-3-phosphate (PI(3)P). In order to study the physiological 
function of SNX27, we have produced mice homozygous for a null mutation of 
SNX27 by gene targeting. Generally, SNX27-/- mice displayed severe growth 
retardation and all died within 3 weeks of age. Retardation of growth was seen in 
most organs as they are all smaller than those in the wild-type littermates. As the 
kidney undergoes extensive postnatal growth and morphogenesis, we have focused on 
the defect of kidney development in SNX27-/- mice. SNX27-/- mice showed a clear 
delay in nephron maturation and developed pronounced lesions in the kidney. The 
urine chemistry analysis of SNX27-/- mice revealed highly upregulated osmolality and 
proteinuria. These lesions were accompanied by increased levels of AQP2 in the 
collecting ducts. In addition, RNAi-mediated knockdown of SNX27 in A431 cells 
was found to inhibit endocytosis of EGFR. Furthermore, through yeast two-hybrid 
screening, we identified a novel SNX27 interacting protein, the N-methyl-D-aspartate 
(NMDA) receptor 2c (NR2c). This interaction was mediated by the binding of the 
PDZ domain of SNX27 with the C-terminal PDZ-binding motif of NR2c. The level of 
NR2c was found to be increased in SNX27-/- mice, implying that SNX27 may 
function to regulate endosomal sorting of NR2c for lysosomal degradation. These 
results suggest that SNX27 may regulate endosomal sorting of membrane proteins 
VII 
 
containing PDZ-binding motif and its absence may alter the trafficking of these 
proteins, leading to survival and organ developmental defects in mice. 
Taken together, the research presented in this thesis reveals the basic biochemical and 
cell biological properties of SNX27 and its important role in maintaining mouse 
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CHAPTER 1: INTRODUCTION 
1.1 Membrane transport 
A defining characteristic of all eukaryotic cells is the presence of membrane-bound 
organelles in addition to the plasma membrane. These organelles include early 
endosomes, recycling endosomes, late endosomes, lysosomes, mitochondria, 
peroxisomes, the Golgi apparatus, the endoplasmatic reticulum (ER) and the nucleus. 
These organelles are distinguished by their specific membrane components and 
functions. However, these organelles have to exchange lipids and proteins and 
communicate through membrane enclosed transport vesicles for maintaining 
structural integrity and function. Many of these organelles are involved in the 
secretory and endocytic pathways, which are dynamically and functionally linked by 
shuttling membrane carriers or vesicles. In the secretory and endocytic pathways, 
membrane-carriers which contain membrane and luminal cargo molecules bud from 
one compartment and fuse with another compartment, a process known as vesicle-
mediated transport (Rothman and Wieland, 1996; Derby and Gleeson, 2007; Pfeffer, 
2007). 
Several pathways can be distinguished in membrane trafficking (Fig. 1.1). Proteins, 
which should be secreted from the cell and membrane proteins of the plasma 
membrane, are transported through the secretory pathways (Lee et al., 2004; Gerdes, 
2008). During their synthesis on ribosomes these proteins are translocated into the ER 
and glycosylated there. Such proteins will be moved via the Golgi apparatus to the 
trans-Golgi network (TGN), during which they receive further glycosylation 
modifications. Sorting of these proteins occurs in the TGN. They can be packaged for 




Lysosomal  proteins are recognized in TGN and transported through the early and late 
endosomes to the lysosomes. For example, the N-linked glycans of newly synthesized 
soluble lysosomal proteins are modified by mannose-6-phosphate. Mannose-6-
phosphate is recognized in the TGN by mannose-6-phosphate receptors, the cation-
independent IGF-II/M6P receptor (MPR-300) and cation-dependent MPR-46 
(Sandholzer et al., 2000; Ghosh et al., 2003a). The complex of lysosomal protein and 
mannose-6-phosphate receptor is transported to the late endosome. Upon dissociation, 
the mannose-6-phosphate receptor then is transported back to the TGN via specific 
interactions with the transport machinery, while lysosomal protein is delivered to the 
lysosome. 
The role of lysosomes is degradation of extracellular and intracellular materials. 
Lysosomal enzymes are transported from the late endosomes to the lysosomes. Some 
lysosomal proteins fail to be transported to the late endosomes. In this case they go 
through the secretory pathway and are secreted from the plasma membrane. These 
escaped lysosomal proteins are recaptured by surface mannose-6-phosphate receptor, 
MPR-300 and reach lysosomes via endocytosis (Kornfeld, 1992; Ghosh et al., 2003a). 
In contrast to mannose-6-phosphate sorting signal for lysosomal enzymes, lysosomal 
membrane proteins contain either tyrosine-based or double-leucine based targeting 
motifs in the cytoplasmic domain for lysosomal targeting (Hamm-Alvarez, 2002). 
On the other hand, extracellular molecules and cell surface receptors are internalized 
from the cell surface and delivered to the early endosome. They can be either 
delivered to the lysosomes through the late endosomes or sorted to other destinations, 
such as back to the surface, or delivered to the TGN. For example, internalized 
receptors for transferrin and epidermal growth factor (EGF), as well as the MPR-46, 




is returned back to the cell surface after being endocytosed. This takes place either 
directly from the early endosome or from the recycling endosome (Maxfield and 
McGraw, 2004). In contrast, EGF receptor, together with the ligand, remains within 
early endosomes which then mature into late endosomes/multivesicular bodies (or 
multivesicular body, MVBs). Fusion of MVB with the lysosome leads to lysosomal 
delivery of EGF receptor (Katzmann et al., 2002).  
 
 
The best studied endocytic pathway involves clathrin, which forms coated membrane 
invaginations on the plasma membrane that recruit cell-surface receptors and then, 
Fig. 1.1: Schematic drawing of membrane trafficking pathways. ER: 





through a series of highly regulated steps, pinch off to form clathrin-coated vesicles 
(Mukherjee et al., 1997; Kirchhausen, 2000a; Fotin et al., 2004). The clathrin coat is 
made up of clathrin triskelions, including three 190 kDa heavy chains and three 25 
kDa light chains, which are required for the formation of the clathrin-coated vesicles 
(CCV) at the plasma membrane, the TGN and possibly endosomes (Fotin et al., 2004; 
Traub, 2005; McNiven and Thompson, 2006). The clathrin triskelion does not have 
the affinity for biological membranes. Cytosolic adaptor complexes are recruited to 
mediate the interaction between the cargo proteins and clathrin to initiate the 
formation of clathrin-coated vesicles (Robinson, 1994; Robinson, 2004).  
Less well characterised, but equally important, are non-clathrin mediated endocytic 
pathways. These include phagocytosis, caveolae-mediated uptake and 
macropinocytosis. Phagocytosis is usually restricted to macrophages and other 
phagocytes that specialise in uptake and digestion of large particles. Other distinct 
non-clathrin mediated endocytic pathways mediate the uptake of smaller cargos. They 
utilise caveolae, macropinosomes or a little-understood constitutive process of plasma 
membrane internalization. A diverse array of molecular machinery is involved, 
including caveolin, ARF6, dynamin, ankyrin/spectrin and actin (Nichols and 
Lippincott-Schwartz, 2001; Mayor and Pagano, 2007; Parton and Simons, 2007).  
1.2 Molecular mechanisms of membrane transport 
The transport of a particular cargo from a donor compartment to a target compartment 
requires a series of different trafficking components (Bonifacino and Glick, 2004; 
Derby and Gleeson, 2007). These trafficking components include adaptor protein 
complexes, coat proteins, tethering factors and soluble NSF attachment protein 




of the components are effector molecules. Their actions are highly controlled by 
regulatory factors. Small G proteins and specific lipids are the main regulatory factors 
in the recruitment of effector molecules for membrane transport (Behnia and Munro, 
2005; Derby and Gleeson, 2007). 
1.2.1 Adaptors and coat proteins 
In order to transport cargo from one membrane compartment to another, cargo 
proteins must be packaged into transport carriers/vesicles. The formation of transport 
vesicles is dependent on cytosolic adaptors which can select membrane cargo. Once 
these adaptors are localized to specific regions of the membrane, they can initiate the 
formation of coated pits by recruiting coat proteins from the cytosol to the membrane. 
Accessory molecules such as small G proteins (Rab or Arf/Arl) and phosphoinositides 
may be involved in the recruitment of these adaptors (Bonifacino and Lippincott-
Schwartz, 2003; Bonifacino and Glick, 2004). Many types of adaptors and coat 
proteins are identified and characterized, including clathrin-associated adaptor protein 
complexes (AP-1, AP-2, AP-3 and AP-4), coatomer protein I (COPI), COPII and 
GGA proteins. Each of these coats functions at specific transport steps along the 
membrane transport pathway (Kirchhausen, 2000b; Bonifacino and Lippincott-
Schwartz, 2003; Lee et al., 2004).  
Adaptor protein complexes are important for clathrin binding to cargo proteins to 
initiate the formation of clathrin-coated pits on the membrane (Robinson, 2004). Until 
now, four adaptor protein complexes (AP-1, AP-2, AP-3 and AP-4) have been 
identified in mammalian cells for various membrane transport steps; each complex is 
heterotetrameric complex consisting of two large subunits, one medium subunit and a 




and crosslink these cargos to clathrin during vesicle formation. AP-1 is predominantly 
associated with the TGN and mediates sorting and transport of MPRs from the TGN 
to the endosome (Le Borgne and Hoflack, 1998; Molloy et al., 1999). AP-2 is 
localized to the plasma membrane and functions in clathrin-dependent endocytosis of 
surface receptors (Bonifacino and Traub, 2003). AP-3 is localized to the TGN and 
endosomes. Its function is probably to sort certain membrane proteins to the lysosome 
or related compartments like melanosomes (Theos et al., 2005). AP-4 is associated 
with perinuclear compartments, possibly the TGN. In experiments with MDCK cells, 
AP-4 was shown to bind basolateral signals and may function in basolateral sorting in 
epithelial cells (Simmen et al., 2002). In addition to the four AP complexes, Golgi-
localized, γ-adaptin ear containing, ARF binding proteins (GGA) also act as clathrin 
adaptors. There are three GGA adaptors, including GGA1, GGA2 and GGA3. They 
are localized to the TGN together with AP-1 and involved in the transport of manose-
6-phosphate receptor (M6PR) from the TGN to the endosome (Doray et al., 2002; 
Ghosh et al., 2003b; Puertollano et al., 2003). Depletion of any one of the GGA 
members can decrease the levels of the other two GGAs, resulting in altered TGN 
morphology and impaired sorting of M6PR into clathrin-coated vesicles at the TGN 
(Puertollano et al., 2001; Zhu et al., 2001; Ghosh et al., 2003a). Even though both 
AP-1 and GGAs are involved in transport of the same cargo in the TGN, they bind to 
different sorting signals present on the cytoplasma tail of M6PR. GGA adaptors binds 
to the DXXLL (where X can be any amino acid) motif. In contrast, AP-1 can bind to 
tyrosine-based sorting motif such as YXXФ (where Ф represents a hydrophobic 
residue) and NPXY for sorting of M6PR into clathrin-coated vesicles (Robinson and 





COPII is a well studied coatomer protein complex. The core components of COPII 
include Sec23/Sec24, Sec13/Sec31 and Sar1. COPII is recruited to the membrane by 
the small GTPase, Sar1, and is specifically involved in the exit of cargo proteins from 
the ER. On the other hand, COPI is made up of seven coatomer subunits (α, β, β’, ε, γ, 
∂ and ζ). COPI is recruited to the membrane by Arf1 GTPase and is involved in 
retrograde transport steps from the Golgi apparatus back to the ER (Rothman, 1994; 
Aridor et al., 1998; Lee et al., 2004; Rabouille and Klumperman, 2005; Tang et al., 
2005). 
1.2.2 SNARE proteins 
The function of SNAREs is to fuse incoming transport intermediates at the target 
compartment. They are a family of small coiled-coil proteins, consisting of a single 
transmembrane helix (a few SNAREs are associated with membrane via lipid 
modification) and a cytoplasmic region containing the SNARE motif, which is a ~60-
residue α-helical domain conserved in all SNARE proteins (Hong, 2005; Jahn and 
Scheller, 2006). The SNARE motif is localized close to the membrane anchor and is 
crucial for SNARE-SNARE interactions and complex formations. 
SNAREs were originally classified into two main classes: v-SNAREs and t-SNAREs. 
V-SNAREs were found on transport intermediates arising from donor compartments 
and have the ability to direct transport intermediates to their target compartments 
(Hong, 2005; Jahn and Scheller, 2006). T-SNAREs were found on the target 
membranes and interact with the v-SNARE present on transport intermediates for 
fusion (Hong, 2005; Jahn and Scheller, 2006). Thus, the original classification was set 
on the basis that v-SNAREs were restricted to transport intermediates and t-SNAREs 




A functional SNARE complex requires an interaction between one v-SNARE on the 
vesicle and three t-SNAREs on the target membrane to form a four-helix bundle for 
membrane fusion (Fig. 1.2). This pairing is known as a trans-SNARE complex and is 
formed prior to membrane fusion. After fusion, the pairing of the SNARE molecules 
is often referred as the cis-SNARE complex because the SNAREs are now on the 
same membrane. The cis-SNARE complexes are dissociated by the ATPase NSF/α-
SNAP and the dissociated v-SNAREs are recycled for another round of fusion (Hong, 
2005; Jahn and Scheller, 2006). Despite the importance of SNAREs in membrane 
fusion, specific fusion events are not solely defined by individual SNARE molecules 
(Hong, 2005; Jahn and Scheller, 2006). Instead, a combination of four individual 
SNARE molecules is required for fusion, indicating that individual SNARE 
molecules may have the ability to participate in multiple SNARE complexes (Hong, 
2005; Jahn and Scheller, 2006). For instance, the t-SNAREs, syntaxin 6, syntaxin 16 
and Vitla can pair with v-SNARE, VAMP3/4 to form a SNARE complex essential for 
fusion of endosome derived transport intermediates at the TGN (Mallard et al., 2002). 
On the other hand, syntaxin 6 can also form another SNARE complex with syntaxin 7, 
Vtilb and VAMP3 for fusion of post-Golgi carriers with the recycling endosome in 
activated macrophages (Murray et al., 2005). Therefore, the specificity of a particular 
SNARE complex is dependent on the combination of SNARE molecules. The 
different combinations of t-SNAREs and v-SNARE can give rise to diverse 
specificities in membrane fusion. 
An alternative structure-based classification is also used to classify SNAREs. This is 
based on whether the central functional residue in the SNARE motif is an arginine (R) 
or a glutamine (Q) residue (Fasshauer et al., 1998). Generally, one R and three Q 




predominantly found on the transport intermediates and function as v-SNAREs while 
Q-SNAREs are generally found at the target compartments and function as t-SNAREs 




1.2.3 Tethering factors 
Despite the ability of individual SNARE protein to participate in more than one 
membrane fusion event, a functional SNARE complex is still not sufficient to 
determine the specificity of membrane fusion. Another class of accessory molecules 
known as tethering factors have been shown to play important role in regulating the 
specificity of membrane fusion. These tethering factors include transport protein 
Fig. 1.2: Schematic drawing of membrane transport through a functional 




particle I and II (TRAPP I and II), conserved oligomeric Golgi (COG), Golgi-
associated retrograde protein (GARP) and exocyst, as well as long filamentous coiled-
coil tethering proteins (Gillingham and Munro, 2003; Liewen et al., 2005; Lupashin 
and Sztul, 2005; Sztul and Lupashin, 2006; Ungar et al., 2006; Cai et al., 2007; Perez-
Victoria et al., 2008). The majority of the tethering factors have been proposed to 
have either a direct or indirect interaction with t-SNAREs in regulating membrane 
fusion at the target membrane (Lupashin and Sztul, 2005; Sztul and Lupashin, 2006). 
Tethering factors can extend to some distance from the target membrane and may 
bind to incoming transport intermediates and bring them into close proximity with the 
target membrane for SNARE complex-mediated fusion (Lupashin and Sztul, 2005; 
Sztul and Lupashin, 2006). Tethering factors are required for membrane fusion at all 
major biosynthetic steps. For example, TRAPP I and TRAPP II are important for the 
ER to TGN transport at different steps (TRAPP I for ER to Golgi transport while 
TRAPP II for intra-Golgi traffic). The GARP complex is required for efficient 
endosome to TGN transport (Liewen et al., 2005; Cai et al., 2007; Perez-Victoria et 
al., 2008). 
1.2.4 Small G proteins 
Small G proteins are expressed in all cell types but their localizations in the cells are 
restricted to particular membrane compartments. Small G proteins cycle between the 
GTP bound and GDP bound form. The GTP-bound form is membrane-associated and 
required for recruitment of specific effector molecules at distinct regions of the 
membrane. The active and inactive form of a G protein is regulated by the guanine 
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). GEFs 
are required for the exchange of GDP to GTP to activate the GTPase, while the GTP 




classes of small G proteins are involved in membrane trafficking, namely the Rab and 
the ARF/Arl (ADP ribosylation factor/ ARF like protein) family (Pasqualato et al., 
2002; D'Souza-Schorey and Chavrier, 2006). Members of the Rab and Arf/Arl 
families are localized to different organelles and recruit distinct sets of effector 
molecules for membrane transport. For instance, Rab5 is localized to the early 
endosome and can recruit effectors such as EEA1, a tethering molecule for membrane 
fusion at the early endosome (Simonsen et al., 1998; Christoforidis et al., 1999). On 
the other hand, Arf6 is localized to the plasma membrane where it recruits 
phosphatidylinositol-5-kinase to generate phosphatidylinositol-4,5-bisphosphate 
(PI(4,5)P2) for clathrin-dependent endocytosis (Krauss et al., 2003; Behnia and 
Munro, 2005; D'Souza-Schorey and Chavrier, 2006). 
1.2.5 Lipids 
Specific lipids, especially phosphoinositides, are involved in the regulation of 
membrane organization. Differential phosphorylation at the 3, 4 and/or 5 position on 
the inositol ring allows for the generation of seven distinct phosphoinositides. They 
are phosphatidylinositol-3-phosphate (PI(3)P), phosphatidylinositol-4-phosphate 
(PI(4)P), phosphatidylinositol-5-phosphate (PI(5)P), phosphatidylinositol-3,4-
bisphosphate (PI(3,4)P2), phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), 
phosphatidylinositol-3,5-bisphosphate (PI(3,5)P2) and phosphatidylinositol-3,4,5-
trisphosphate (PI(3,4,5)P3). Their formation is regulated by the action of different 
lipid kinases and phosphates (De Matteis and Godi, 2004; Wenk and De Camilli, 
2004; Behnia and Munro, 2005). Phosphoinositides are important for compartment-
specific recruitment of various cytosolic proteins to distinct post-Golgi membranes 
such as the plasma membrane, the early endosome and the TGN due to their regulated 




structural domains. For example, a critical component in endosomal homeostasis is 
PI(3)P (Gillooly et al., 2003; Vicinanza et al., 2008). This lipid is involved in 
modulating early and late stages of endosome function through its interaction with a 
variety of functional protein domains, including the Phox (PX) domain and the FYVE 
domain (Lemmon, 2003; Birkeland and Stenmark, 2004). For example, the FYVE 
domain containing protein EEA1 is involved in modulating early endosomal 
dynamics by regulating homo- and heterotypic endosome fusion (Rubino et al., 2000; 
Lawe et al., 2002; Birkeland and Stenmark, 2004), whereas Hrs, another FYVE 
domain-containing protein, controls later events in sorting selected cargo for 
degradation, away from that destined for recycling (Raiborg et al., 2001). Unlike 
PI(3)P, the precise role of PI(3,5)P2 in endosomal function remains elusive. This is 
mainly due to the lack of described PI(3,5)P2 effectors. However potential effectors 
have recently been identified, including Ent3p (Friant et al., 2003), hVps24p (Whitley 
et al., 2003), WIPI49 (Jeffries et al., 2004) and sorting nexin 1 (SNX1) (Cozier et al., 
2002). 
1.3 The PX domain 
The Phox (PX) domain is a phosphoinositide binding domain involved in targeting 
proteins to endosome membranes. This domain averaging 120 amino acids in length 
was first identified through the analysis of two of the cytosolic components of the 
NADPH oxidase, p47phox and p40phox (Ponting, 1996). The PX domain is 
evolutionarily conserved from yeast to human. Currently, at least 47 human and 15 
yeast proteins that contain PX domain have been identified, such as sorting nexins, 
Phospholipase D (PLD) and CISK (identical to SGK3, the serum- and glucocorticoid-




Several studies from a number of laboratories have shown that PX domain interacts 
primarily with PI(3)P. Xu et al. from my host laboratory demonstrated that SNX3, a 
short PX domain protein, preferentially bound to PI(3)P (Xu et al., 2001a). Similarly, 
it was also demonstrated that PX domains of Vam7, P40phox and SNX16 could bind to 
PI(3)P (Cheever et al., 2001; Kanai et al., 2001; Hanson and Hong, 2003). However, 
some PX domain proteins can also bind to other phosphate lipids, including 
phosphatidic acid, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2 and PI(3,4,5)P3. For example, it has 
recently been reported that the PLD1-PX domain does not specifically bind to PI(3)P 
but rather binds to PI(3,4,5)P3 (Stahelin et al., 2004). SNX1-PX binds with similar 
affinities to PI(3)P and PI(3,5)P2 (Cozier et al., 2002). Collectively, different PX 
domains may bind to different phosphoinositides and target their host proteins to 
distinct sub-cellular compartments.  
The crystal structures of many PX domains have been solved, such as p47phox, Vam7p 
and Grd19p/SNX3 (Bravo et al., 2001; Lu et al., 2002; Zhou et al., 2003). The 
illustrative structure of a typical PX domain, p47phox-PX, is shown in Fig. 1.3. The 
overall structure of the PX domain consists of a common phosphoinositide-binding 
fold/pocket made up of three stranded β-sheets (β1−β3) from N-terminal portion 






The interactions in this pocket involve hydrogen bonds between the negative charges 
of phosphoinositides and positively charged residues of the PX domain. For example, 
the mutation of p47phox-PX (Arg90 to Leu) significantly reduced the hydrogen bonds 
with the 3-phosphate of PI(3)P (Ponting, 1996). Most of the side chains involved in 
the interaction with the head group of PI(3)P are conserved among the identified PX 
domains, For example, mutation of the three residue R69RY of SNX3 into A69AA 
abolished PI-binding ability (Xu et al., 2001a). In addition, some PX domain 
containing proteins have a proline rich motif (PXXP) in the middle, such as p47phox. 
PXXP is characterized as SH3 domain binding motif (Ponting, 1996; Babior, 1999). 
Hiroaki et al. demonstrated that p47phox is able to bind its own C-terminal SH3 domain 
through this proline rich motif (Hiroaki et al., 2001). Furthermore, Segal’s laboratory 
reported PX domain of p47phox is also able to interact with moesin, a protein that links 
F-actin to the plasma membrane (Wientjes et al., 2001). Thus, PX domain not only 
acts as a lipid binding platform, but is also a protein-protein interacting domain. 
1.4 Sorting Nexin family 
Fig. 1.3: Illustrative structure of the PX domain of p47phox (PDB 1KQ6). The 
structure was viewed by PyMol program (http://www.pymol.sourceforge.net/) and 




Sorting nexins (SNXs) are a sub-group of peripheral membrane proteins containing a 
conserved SNX-PX domain that targets SNX to endosomes (Worby and Dixon, 2002; 
Seet and Hong, 2006; Cullen, 2008). Until now, 33 mammalian SNXs and 10 yeast 
SNXs have been identified, although for the majority of them, little is known for their 
functions.  
Based on the molecular and structural analysis, the sorting nexin family members can 
be divided into three sub-groups. The first sub-group includes SNX1, SNX2, SNX4, 
SNX5, SNX6, SNX7, SNX8, SNX9, SNX18, SNX30, SNX32 and SNX33. They 
contain a PX domain and an additional Bin/Amphiphysin/Rvs (BAR) domain at the 
C-terminus, which may function in self- or heter-oligomerzision and mediate 
formation of membrane curvature (Habermann, 2004). The second sub-group includes 
SNX3, SNX10, SNX11, SNX12, SNX20, SNX22 and SNX24. They are either short 
SNXs that contain essentially a PX domain or longer SNXs that contain an additional 
coiled-coil domain besides the PX domain. The last sub-group includes the remaining 
SNXs such as SNX13, SNX17, SNX23 and SNX27. In addition to the PX domain, 
they contain multiple protein functional domains such as SH3 (Src homolog 3) 
domain, RGS (Regulator of G-protein Signaling) domain, PDZ (PSD95/Dlg/ZO1) 
domain or RA (Ras Association) domain (Worby and Dixon, 2002; Seet and Hong, 
2006; Cullen, 2008) (Fig. 1.4). From many research reports, SNXs are implicated in 
the regulation of protein transport along the endocytic pathway and each SNX 
exhibits unique cellular function. 
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Fig. 1.4: Domain architecture of the mammalian sorting nexins. The key 







SNX1 is the prototype member of the SNX family. It was identified in a yeast two-
hybrid screening for proteins capable of interacting with the cytoplasmic tail of the 
epidermal growth factor receptor (EGFR) (Kurten et al., 1996). Kurten et al. showed 
that overexpression of SNX1 can accelerate the EGFR degradation after being 
released from the sorting endosome. One possible mechanism is that over-expressed 
SNX1 enhances the rate of endosome maturation thereby affecting EGFR trafficking.  
SNX1 and its homologue SNX2 together with Vps35, Vps29 and Vps26 are identified 
as a large protein complex, named retromer. SNX1 has also been proposed to interact 
with two other SNXs, namely SNX5 and SNX6 in mammalian cells (Kerr et al., 2006; 
Wassmer et al., 2007). Subsequently, SNX5 and SNX6 are also proposed to take part 
in the formation of retromer complex (Wassmer et al., 2007). A specific role for 
retromer in trafficking of CI-M6PR from the endosome to the TGN was initially 
described in yeast, in which a genetic screen was carried out to isolate mutants which 
have a defect in sorting Vpsl0p (yeast homologue of M6PR) to the vacuole (yeast 
equivalent of lysosome). A vesicle coat complex consisting of Vps35p, Vps29p, 
Vps26p, Vps5p and Vpsl7p was identified from genetic screens and biochemical 
experiments (Seaman et al., 1998; Nothwehr et al., 2000). Most components of the 
yeast retromer are found to be evolutionarily conserved as mammalian orthologues. 
Vps35, Vps29 and Vps26 were readily identified using bioinformatics (Edgar and 
Polak, 2000; Haft et al., 2000). Unlike the data present for yeast, the relationship 
between mammalian Vps subunits and the SNX dimer is less clear. The identity and 
exact composition of the mammalian equivalent of the SNX dimers have not been 
defined (Gullapalli et al., 2004; Merino-Trigo et al., 2004; Gullapalli et al., 2006; 
Kerr et al., 2006; Shi et al., 2006). Both SNX1 and SNX2 have been suggested to be 




other hand, both SNX5 and SNX6 have also been proposed to be the mammalian 
orthologues of yeast Vpsl7p based on a functional RNAi screen for defects in CI-
M6PR recycling (Wassmer et al., 2007). Vps26, Vps29 and Vps35 can form a trimer 
complex that is thought to participate in cargo recognition, while the SNX dimer is 
thought to be involved in generation of transport intermediates for transport from the 
early endosome to the TGN (Carlton et al., 2004; Seaman, 2004; Carlton et al., 2005; 
Rojas et al., 2007). The interaction between components of the mammalian retromer 
has been demonstrated using a number of in vitro and in vivo approaches. By yeast 
two-hybrid and immunoprecipitation experiments, SNX1 could bind directly to Vps35 
and Vps29, and SNX1 and SNX2 can form either homodimers or heterodimers with 
each other or with SNX5 and SNX6 (Haft et al., 2000; Gullapalli et al., 2004; Kerr et 
al., 2006; Rojas et al., 2007; Wassmer et al., 2007). In addition, gel filtration analysis 
showed that mammalian orthologues of the yeast retromer forms a multimeric 
complex in both transfected COS7 cells and rat liver cytosol (Haft et al., 2000). By 
immunofluorescence microscopy, components of the mammalian retromer, Vps26, 
Vps29, Vps35, SNX1/SNX2 and SNX5/SNX6 are localized to punctuate structures 
positive for EEA1 in cultured cells, suggesting that the mammalian retromer functions 
at the early endosome (Arighi et al., 2004; Carlton et al., 2004; Merino-Trigo et al., 
2004; Seaman, 2004; Carlton et al., 2005). The depletion of Vps26 or Vps35 in HeLa 
cells led to a significant reduction of the two other Vps subunits, suggesting that the 
loss of one component of the trimeric Vps26-Vps35-Vps29 complex would lead to 
instability of the whole complex (Arighi et al., 2004; Seaman, 2004; Rojas et al., 
2007). In contrast, the silencing of Vps26 and Vps35 did not significantly alter the 





Early works from Cullen’s laboratory showed that SNX1-containing tubules arising 
from endocytic-like structures co-localized with similar tubular structures labeled for 
the CD8-M6PR fusion protein, indicating that SNX1-marked tubules are involved in 
CI-M6PR transport from the early endosome (Carlton et al., 2004). The silencing of 
SNX1 by siRNA disrupted recycling of endogenous CI-M6PR and the CD8-M6PR 
reporter (Carlton et al., 2004; Seaman, 2004). In SNX1 depleted cells, CI-M6PR was 
not TGN localized but rather distributed into punctate structures that co-localized with 
markers of the early endosome, suggesting that SNX1 is essential for the early 
endosome to TGN transport of CI-M6PR (Carlton et al., 2004; Seaman, 2004). 
Given that SNX2 has been reported to dimerise with SNX1, the silencing of SNX2 
would be expected to lead to the missorting of CI-M6PR (Haft et al., 2000; Gullapalli 
et al., 2006). However, this was not the case. RNAi silencing of SNX2 did not 
significantly block recycling of CI-M6PR and the receptor was concentrated at the 
TGN at steady state (Carlton et al., 2005). These results suggest that SNX2 may not 
be essential for retrograde transport of CI-M6PR and indicate that SNX1 and SNX2 
may have independent functions in membrane transport. In support of this proposal, 
Gullapalli et al. showed that SNX1, but not SNX2, was important for the sorting of 
another endosomal cargo, protease-activated receptor 1 (PAR1), from the endosome 
to the lysosome (Gullapalli et al., 2006). 
The proposal for the interchangeable role of SNX1 and SNX2 is supported by an 
absence of any significant defect in development in SNX1 and SNX2 knockout mice 
and only a double knockout of both SNX1 and SNX2 genes in mice resulted in 
embryonic lethality (Schwarz et al., 2002; Griffin et al., 2005). This suggests SNX1 





Collectively, four members of the mammalian SNX family, SNX1/SNX2 and 
SNX5/SNX6, have been proposed to associate with retromer to regulate retrograde 
transport of CI-M6PR (Carlton et al., 2004; Carlton et al., 2005; Rojas et al., 2007; 
Wassmer et al., 2007). In addition, the different combination of SNX dimers 
SNX1/SNX2 and SNX5/SNX6 may regulate transport of different cargos by the 
generation of distinct domains and /or tubules at the early endosome. 
1.4.2 SNX3 
SNX3 is a short SNX that contains short flanking sequences other than the PX domain. 
Xu et al. from my host laboratory showed SNX3 interacts with PI(3)P and localizes in 
the early endosome (Xu et al., 2001a). The RRY motif (aa 69-71) of the PX domain is 
critical for membrane targeting. Overexpression of SNX3 caused a massive expansion 
of an endosomal compartment which was a characteristic of the mixture of the early, 
recycling and late endosomes. Xu et al. also indicated that the transport of transferrin 
from the early endosome to the recycling endosome was delayed after micro-injecting 
rabbit anti-SNX3 antibodies. This experiment suggests that SNX3 functionally 
regulates the membrane trafficking from the early to the recycling endosome. The 
observed effect is probably due to the physiological changes in the early endosomes, 
but the exact mechanism remains unclear. On the other hand, the yeast homologue of 
SNX3, Grd19/Snx3p directly associates with Ftr, an iron transporter, and promotes 
the sorting of this cargo from the prevacuolar endosome to the Golgi apparatus 
(Strochlic et al., 2007). 
1.4.3 SNX4   
In yeast, Snx4 together with Snx41, Snx42 are grouped as a sorting complex that 




Cullen’s laboratory reported the suppression of mammalian SNX4 in HeLa cells 
delayed the transport of transferrin receptor (TfR) to the recycling pathway (Traer et 
al., 2007). Traer et al. proposed an intermediate protein complex may participate in 
the TfR sorting process. In their report, they identified the KIBRA, a dynein-binding 
protein, associated with SNX4. Thus, SNX4 may indirectly mediate TfR sorting back 
to the recycling endosome by regulating the membrane tubules exiting from the early 
endosome. 
1.4.4 SNX5/SNX6 
SNX5 shows 66% identity at amino acid sequence level with SNX6 (Parks et al., 
2001). Besides their function as a component of the mammalian retromer complex 
(Wassmer et al., 2007), SNX5 has also been shown to bind to the FANCA (Fanconi 
anemia, complementation group A) protein in the yeast two-hybrid assay. 
Overexpression of SNX5 can increase the FANCA protein levels (Otsuki et al., 1999). 
In year 2001, Parks et al. reported SNX6 interacts with members of receptor serine-
threonine kinases of the TGF-β family. SNX6 forms homo- or hetero-dimers with 
SNX1, SNX2 and SNX4, but not SNX3. SNX6 can interact with EGF receptor, 
PDGF receptor, insulin receptor and leptin receptor (Parks et al., 2001). 
1.4.5 SNX9 
SNX9 is also known as SH3PX1. It contains a SH3 domain which can bind to proline-
rich motifs in proteins such as ACK2 (Lin et al., 2002) and a BAR domain which 
functions in dimerization (Peter et al., 2004). SNX9 was reported to facilitate the 
endocytosis and degradation of EGFR through stabilizing the interaction between 




plasma membrane (Lundmark and Carlsson, 2003; Lundmark and Carlsson, 2004). 
Thus, it might therefore participate in regulating clathrin-dependent endocytosis. 
Indeed, over-expressed C-terminally truncated SNX9 in K562 and HeLa cells has 
been shown to inhibit transferrin uptake (Lundmark and Carlsson, 2003). Furthermore, 
Macaulay et al. reported that microinjection of an antibody against SNX9 could 
inhibit the translocation of the insulin-responsive glucose transporter GLUT4 to the 
cell surface in insulin-stimulated 3T3L1 cells (MaCaulay et al., 2003). Subsequent 
study showed siRNA-mediated knockdown of SNX9 in BSC1 cells abolished the 
efficient formation of PDGF-induced dorsal ruffles on the plasma membrane (Yarar et 
al., 2007). These observations suggest that SNX9 functions in the coordination of 
membrane remodelling and fission via direct interactions with several actin-regulating 
proteins and endocytic proteins. 
1.4.6 SNX13 
SNX13 (RGS-PX1) contains both RGS domain and PX domain. Early studies have 
shown that SNX13 function as a GAP for Gαs that attenuates Gαs-mediated signalling 
through its RGS domain (Zheng et al., 2001). In addition, as a SNX, SNX13-PX 
domain alone strongly binds to PI(3)P and PI(5)P and weakly to PI(3,5)P2. SNX13 is 
co-localized with the early endosome marker EEA1 in COS7 cells, which indicates it 
may functionally regulate membrane transport. Indeed, overexpression of SNX13 
results in a delay of EGFR lysosomal transport, suggesting SNX13 has an opposite 
effect of SNX1 (Zheng et al., 2001). 
Recently, the genetic analysis has provided further insight into the role of SNX13 in 
mice development. SNX13-/- mice were generated in Lehtonen’s laboratory and the 




2006). Extensive analysis indicated dramatic pathological changes in the SNX13-null 
visceral yolk sac endoderm cells. The abnormal localization of several endocytic 
markers, including megalin, ARH and LAMP2 was noted (Zheng et al., 2006). 
Collectively, these studies suggest SNX13 not only can act as a GAP for G protein 
signalling, but also exhibits the function of a SNX to regulate vesicular trafficking. 
1.4.7 SNX15 
SNX15 was identified through the database search for PX domain proteins (Barr et al., 
2000; Phillips et al., 2001). Barr et al. reported that overexpression of SNX15 disrupts 
the organization of endosomes, and results in the appearance of large amorphous 
structures, containing the early endosome, the late endosome and the lysosome. 
Therefore the internalization of PDGFR, Furin and TfR is delayed (Barr et al., 2000). 
SNX15 can directly interact with PDGFR. The PX domain is required for the 
membrane association and the interaction between SNX15 and PDGFR (Phillips et al., 
2001). 
1.4.8 SNX16 
SNX16 is a newly identified SNX family member. Recent studies from my host 
laboratory and Suh’s laboratory both reported that SNX16 could regulate EGFR 
trafficking (Hanson and Hong, 2003; Choi et al., 2004). SNX16 is the only SNX that 
has been shown to partially co-localize with the late endosome marker LAMP1. The 
intact C-terminal coiled-coil domain is critical for the late endosomal localization 
(Hanson and Hong, 2003). In addition, Choi et al. reported that the PX domain of 
SNX16 not only participated in lipid binding but also participated in self-






SNX17 was identified as a P-selecting interacting partner in yeast two-hybrid 
screening (Florian et al., 2001). This interaction is PX domain independent but the 
SNX17-FERM domain dependent. P-selectin is a cell adhesion molecule that is stored 
in the secretory granules of endothelial cells and can be transported to the plasma 
membrane upon cell activation. Thus, SNX17 may functionally regulate the 
endocytosis of P-selectin. Stockinger et al. demonstrated SNX17 interacts with low-
density lipoprotein receptor (LDLR) family proteins such as LDLR, VLDLR, 
ApoER2 and LDLR-related protein (LRP) through the PX domain. RNAi-mediated 
knockdown of SNX17 resulted in increased LRP lysosomal degradation (Stockinger 
et al., 2002). In a recent study, Lee et al. reported SNX17 interacts with Amyloid 
Precursor Protein (APP) and facilitates its endosomal trafficking (Lee et al., 2008). 
These results indicate SNX17 may regulate the recycling of surface protein such as P-
selectin and LRP from the sorting endosome to the plasma membrane, suggesting 
SNX17 is functionally important in the endocytosis and recycling pathways. 
1.4.10 SNX23 
SNX23 was initially named as KIF16B which is a member of the kinesin-3 family. 
Like most kinesin-3 family members, SNX23 participates in plus-end organelle 
transport (Hoepfner et al., 2005; Miki et al., 2005). Overexpression of KIF16B re-
locates early endosomes to the cell periphery and inhibits protein transport to the 
degradation pathway (Hoepfner et al., 2005). On the other hand, RNAi-mediated 
knockdown of KIF16B causes clustering of early endosomes to the perinuclear region, 
thus accelerating EGF-induced EGFR degradation (Hoepfner et al., 2005). These 




regulate the intracellular motility of the early endosomes. Recent work from the 
collaboration of Cho’s laboratory and my host laboratory (with my full participation) 
has elucidated the structural basis of this unique endosomal anchoring activity of 
KIF16B-PX domain by determining the crystal structure of the PX domain (Blatner et 
al., 2007). By performing in vitro and cellular membrane binding measurements for 
KIF16B-PX and mutants, our study showed that the side chains of L1248 and F1249 
are important for maintaining a tight membrane association of KIF16B-PX domain 
(Blatner et al., 2007).  
1.4.11 SNX27 
Initially, SNX27 was identified in rat as products generated by alternative splicing of 
the Mrt1 (methamphetamine responsive transcript 1) gene. SNX27 comprises two 
variants, SNX27a and SNX27b. SNX27a is expressed constitutively in the brain and 
testis, whereas the SNX27b isoform is induced in brain following methamphetamine 
treatment (Kajii et al., 2003). As a PX domain protein, SNX27 co-localizes with 
EEA1 in the early endosome and TfR in the recycling endosome (Rincon et al., 2007). 
In addition, SNX27 uniquely contains a PDZ domain among all the PX domain 
proteins. It has been reported to be an interaction partner of several proteins such as 
the cytohesin associated scaffolding protein (CASP), 5HT4a receptor, diacylglycerol 
kinase δ (DAKδ) (collaborative work with my participation) and Kir 3 channels. They 
all contain a class I PDZ binding motif (S/TXФ, where Ф represents a hydrophobic 
residue) at the very C-terminus (Joubert et al., 2004; MacNeil et al., 2007; Rincon et 
al., 2007; Lunn et al., 2007). In year 2004, Joubert et al. reported that in A431 cells, 
overexpression of SNX27 can recruit the 5HT4a receptor from the plasma membrane 
to the early endosome, but the PDZ domain-deleted form (SNX27ΔPDZ) failed to 




Subsequently, Merida’s laboratory collaborated with my host laboratory (with my 
participation) and reported that in T lymphocytes, SNX27 interacts with DAKδ and 
may regulate protein transport in the recycling pathway (Rincon et al., 2007). The 
recent study from Slesinger’s laboratory has identified a physiological role of SNX27 
in mediating the neuronal potassium channel Kir3 endocytosis from cell surface 
(Lunn et al., 2007). SNX27 co-localizes with Kir3 channel in the early endosome 
which is marked by EEA1. SNX27 specifically interacts with Kir3.2c and Kir3.3, 
which both contain the class I PDZ binding motif. Besides the PDZ binding motif, 
Kir3.3 contains an additional C-terminal lysosomal targeting motif YXXФ. SNX27 
promotes the Kir3.3 early endosomal targeting, and co-expression of SNX27 and 
Kir3.1 accelerates Kir3.3 lysosomal trafficking, resulting in reduced surface 
expression of Kir3.3. In contrast, the Kir3.2c does not contain the lysosomal targeting 
motif. Thus the depletion of SNX27 could alter the surface recycling rate of Kir3.2c 
from the early endosome to the plasma membrane. In cells co-expressing of SNX27 
and Kir3.3, the surface expression of Kir3.2c is significantly reduced. These results 
suggest that SNX27 might regulate the endocytosis of Kir3 channel in a PDZ domain 
dependent manner.  
Collectively, the above studies suggest SNX27 plays a crucial role in protein 
trafficking and membrane targeting through the PDZ and the PX domains. But the 
function of the SNX27-RA domain and, as a SNX, whether or how SNX27 would 
regulate EGFR or PDGFR endocytosis pathways has not been addressed yet. 
Furthermore, the physiological function of SNX27 in vivo remains to be investigated.   
 
1.5 Application of RNAi in cell biology 




facilitate the inhibition of gene expression by introducing double-stranded RNA 
(dsRNA) are present in most eukaryotic organisms and play functional roles in 
regulating gene expression (Dykxhoorn et al., 2003; Du and Zamore, 2005; 
Wienholds and Plasterk, 2005). 
Interference RNA (RNAi) is now widely used as an experimental tool to investigate 
the function of a protein or a pathway of choice. RNAi was discovered in 
Caenorhabditis elegans as a response to double-stranded RNA (dsRNA) which results 
in sequence specific gene silencing (Fire et al., 1998). There are three types of RNAi 
technologies currently. These include synthetic small interfering RNA (siRNA), the 
vector based short hairpin RNA (shRNA) and microRNA (miRNA) systems (Elbashir 
et al., 2001; Carrington and Ambros, 2003; Kohan, 2008). 
1.6 Targeted gene replacement as a tool to study the functions of mammalian 
genes 
Mutants are the most important tools for assigning biological functions to genes. 
Targeted mutation can be generated in a selected gene by inserting mutant copies of 
the gene into cells and screening for cells in which the mutant copy has taken place of 
the original gene on a chromosome by homologous recombination (Wienholds and 
Plasterk, 2005; Kohan, 2008). Such altered cells are helping researchers to produce 
mice carrying specific genetic mutations. The currently available technologies for in 
vitro manipulation of mouse embryonic stem cells have opened up new areas in 
mammalian genetics. Gene targeting technologies allow asking questions as to the in 
vivo functions of a specific gene in the context of the whole animal or different cell 
types. 




Over 30 sorting nexins and close to 50 PX domain proteins have been identified, but 
the physiological function for many of them remains elusive. Among the 50 or so 
Phox (PX) domain proteins, SNX27 is the only one that contains a PDZ domain. 
Recent studies have provided evidence for a role of SNX27 in regulating protein 
trafficking in the endocytic pathway (Joubert et al., 2004; Rincon et al., 2007; Lunn et 
al., 2007).  
The aim of this study is to systematically characterize the biochemical and cell 
biological properties of SNX27 and use gene knockout strategies to define its 
physiology functions. 
Our study of the biochemical property of SNX27 has demonstrated the function of the 
SNX27-PX domain is for lipid binding and membrane targeting. In addition, we 
introduced shRNA of SNX27 into A431 cells to knockdown SNX27 and identified 
the effect on the EGFR endocytosis pathway. Furthermore, we screened for SNX27 
interacting proteins through yeast two-hybrid assays and identified a novel SNX27 
interaction partner, the N-methyl-D-aspartate (NMDA) receptor 2C (NR2c). 
In order to explore the physiological roles of SNX27 during mice development, 
SNX27 knockout mice were generated by homologous recombination. Our study 
suggests that SNX27 is an essential gene for mice postnatal development. Extensive 
analysis on the kidney provides useful understanding of the role of SNX27 in 







CHAPTER 2: MATERIALS AND METHODS 
This chapter describes various techniques and reagents used in this study. 
 
2.1 cDNA cloning  
DNA manipulation: 
1) Dephosphorylation of vectors: 
Calf intestinal alkaline phosphatase (CIAP, New England Biolab, Beverly, MA, USA) 
was added to the digestion mixture of vector and incubated for 1 hr at 37 °C. The 
vector DNA was then purified by QIAEX Gel Extraction Kit (QIAGEN, Hilden, 
Germany). 
2) PCR reactions: 
PCR reactions performed in this study were done using Advantage 2 polymerase 
(Clontech, Palo Alto, CA, USA) unless otherwise indicated, with PTC225 Thermal 
Cycler (MJ Research, Waltham, MA, USA). The cycle parameters are as follows: 
95 °C: 4 min 
94 °C: 30 sec 
55 °C: 45 sec                 30 cycles 
72 °C: X sec 
72 °C: 10 min 
The extension time X was calculated based on 1 min per 1 kb of amplified DNA. 





The following vectors are used in this study: pCI-neo is from Promega (Madison, WI, 
USA); pGEX-4T-1 is from Amersham (Little Chalfont, UK); pDMyc-Neo and 
pDHA-Neo are modified version of the pCI-neo vector made in our laboratory (Seet 
and Hong, 2001); pGBKT7 is from Clontech; pSuper.Retro.puro vector is from 
Oligoengine (Seattle, Washington, USA).  
Constructs 
SNX27 was identified through a Blast search of the NCBI human EST database for 
proteins homologous to the protein sequence of the SNX1-PX domain. SNX27 has 
two isoforms SNX27a (GenBank accession number CAH73502) and SNX27b 
(GenBank accession number NP_112180). The coding region of both isoforms of 
SNX27 was amplified by PCR from a human Universal Quick Clone cDNA library 
(Clontech) using Advantage 2 polymerase (Clontech) and specific primers for the 
common 5’ end (ATGGCGGACGAGGACGGGGAAGGGATT) and the specific 3’ 
end of SNX27a (CTAGGTGGCCACATCTCTCTGCTGTGACCT) or SNX27b 
(CTAATATTCCTCTTTTCTCCACTTGAGCTC). A 5’ XhoI site and a 3’ NotI site 
were introduced during PCR amplification. Both SNX27a and SNX27b were 
subcloned into pDMyc-Neo and pDHA-Neo vectors using XhoI and NotI sites. 
Deletion mutants were generated using PCR and cloned into the vectors as listed 
above. The construct of rat NMDA Receptor-2c full-length (pBluescript-NR2cFL) 
was a gift from Dr. Shigetada Nakanishi (Kyoto University, Japan). Deletion mutants 
were generated using PCR and cloned into vectors as mentioned above. All clones 





Table 1. List of DNA plasmid constructs made for this study. 
Name Insert Vector Purpose in this study 
Myc-SNX27a Human SNX27a 
full-length 
pDMyc-Neo Expression of the SNX27a-FL 
protein in mammalian cells 
Myc-SNX27b Human SNX27b 
full-length 
pDMyc-Neo Expression of the SNX27b-FL 
protein in mammalian cells 
Myc-SNX27NT Human SNX27 
aa 1-266 
pDMyc-Neo Expression of the SNX27 N-





aa 147-541   
pDMyc-Neo Expression of the SNX27 with 





deleted aa 147- 
287  
pDMyc-Neo Expression of the SNX27a 
with deletion of the PX domain 




aa 287-541   
pDMyc-Neo Expression of the SNX27a C-
terminal region in mammalian 
cells 
Myc-SNX27PX Human SNX27 
aa147- 287 
pDMyc-Neo Expression of the SNX27 PX 
domain in mammalian cells 
HA- SNX27aFL Human SNX27a 
full-length 
pDHA-Neo Expression of the SNX27a-FL 




aa 147-541   
pDHA-Neo Expression of the SNX27a 
with deletion of the PDZ 




deleted aa 147- 
287 
pDHA-Neo Expression of the SNX27a 
with deletion of the PX domain 
in mammalian cells 
GST-SNX27NT Human SNX27 
aa 1-266 
pGEX4T-1 Expression of the SNX27 N-
terminal region in bacteria 
strain BL21 
GST-SNX27PX Human SNX27  
aa147- 287 
pGEX4T-1 Expression of the SNX27 PX 






pGBKT7 For yeast two-hybrid analysis 





pGBKT7 For yeast two-hybrid analysis 








aa 147-541   
pGBKT7 For yeast two-hybrid analysis 
as Gal4-BD fusion protein 
pGBKT7-
SNX27 a∆PX  
Human SNX27a 
deleted aa 147- 
287 
pGBKT7 For yeast two-hybrid analysis 




aa 287-541   
pGBKT7 For yeast two-hybrid analysis 
as Gal4-BD fusion protein 
pGBKT7-
SNX27 a∆RA  
Human SNX27a 
aa 1-460 
pGBKT7 For yeast two-hybrid analysis 
as Gal4-BD fusion protein 
Myc-NR2c-CT Rat-NR2c 
aa1066-1236 
pDMyc-Neo Expression of the NMDA 
receptor type 2C C-terminal 





pDMyc-Neo Expression of the NMDA 
receptor type 2C C-terminal  
region with deletion of the 
SEV motif in mammalian cells 
 
2.2 Expression and purification of GST-fusion proteins 
GST-fusion proteins were purified according to Amersham Pharmacia’s protocol. 
SNX27NT coding sequences were cloned into pGEX4T1 vector, and the DNA 
sequences were confirmed in frame and without mutations.  
1) Transform the DNA constructs into BL21 competent cells and pick 3 colonies from 
each dish into 3 ml LB/ampicillin (100 μg/ml, Sigma, St. Louis, MO, USA) with 
vigorous shaking overnight at room temperature.  
2) Inoculate 5 ml of LB medium containing 50 μg/ml ampicillin with 50 μl of each 
overnight culture. Incubate the cultures for more than 2 hr at 37°C in a shaking 
incubator until mid-log growth (OD 600nm of 0.5-1.0).  
3) Place the day culture in cold room for 10 min, then add IPTG to a final 




The final concentration of IPTG could be adjusted in the range of 0.1-2 mM, 
depending on the property of individual protein. The working concentration of IPTG 
is 1 M. 
4) The cells were centrifuged at 4000Xg for 15 min at 4ºC, and the pellets were 
resuspended in phosphate-buffered saline (PBS) buffer. Lysis of pelleted cells was 
done by sonication at 4ºC. Cell lysates were clarified by centrifugation and the 
supernatant was incubated with column glutathione Sepharose 4B (Amersham 
Pharmacia) for 4 hr at 4 ºC, and were washed 5 times with cold-PBS. GST-fusion 
protein was eluted with 10 mM reduced glutathione in GST purification buffer (50 
mM Tris-Cl, pH 8.5 and 150 mM NaCl) or digested by incubated with thrombin 
(diluted in GST purification buffer) for 6 hr at room temperature. Purified proteins 
were stored at -20 ºC. 
2.3 Immunization of rabbits and affinity purification of antibodies  
Anti-SNX27 polyclonal antibodies were raised by injecting purified GST-SNX27NT 
fusion protein into rabbits with Freud’s complete adjuvant (Piece, Rockford, IL, USA). 
Booster injections with the antigens in Freund’s incomplete adjuvant were 
administered every 20 days, and 50 ml antiserum bleed was recovered after the 4th 
injections and thereafter. A total 200 ml blood was collected from each rabbit. Anti-
SNX27 serum was purified using an affinity matrix prepared by chemically coupling 
the antigen to glutathione-Sepharose using dimethyl pimelimidate dihydrochloride 
(Sigma, St. Louis, MO, USA). Antibody bound to the Sepharose was eluted with 
ImmunoPure IgG elution buffer (Pierce, Rockford, IL, USA) and neutralized in 1 M 
Tris-HCl, pH 8. The antibody was then dialyzed against PBS, and concentrated using 




 Specific blocking of the antibody with its antigen was achieved by incubating the 
antibody with a 50-fold excess of GST-SNX27NT fusion protein overnight at 4ºC. 
Non-specific blocking was similarly carried out with GST-SNX16FL fusion protein. 
2.4 Antibodies used in the study 
Table 2. List of used primary antibodies in this study. 
Name Immunised species Reference 
EGFR Mouse, monoclonal BD Transduction (San 
Diego, CA, USA) 
EEA1 Mouse, monoclonal BD Transduction 
 LAMP2 Mouse, monoclonal Hybridoma  
GS28 Mouse, monoclonal Hybridoma 
Mouse, monoclonal  Hybridoma      Myc 
Rabbit, polyclonal Upstate Biotechnology 
(Charlottesville, VA, 
USA) 
HA Rabbit, polyclonal Upstate Biotechnology 
β-actin Mouse, monoclonal Sigma 
AQP2 Chicken  Gift from Dr. Knepper’s 
lab. (Barile et al., 2005) 
Kir3.1, Kir3.2c and 
Kir3.3 
Rabbit, polyclonal Alomone laboratory 
(Jerusalem, Israel ) 





The secondary fluorescein isothiocyanate (FITC), AlexaFluor 555 and Texas Red-
conjugated anti-mouse or anti-rabbit antibodies were from Jackson ImmunoResearch 
(West Grove, PA, USA).  
2.5 Cell lines used in the study  
A431, COS7, HeLa, MCF7, HEK293T, NRK, PC12 and AtT-20 were purchased from 
the American Type Culture Collection (ATCC, Manassas, VA, USA). MIN6 cells 
were kindly provided by Dr. Junichi Miyazaki (Osaka University, Osaka, Japan). 
Phoenix-Ampho and Phoenix-Eco cells were gifts from Nolan Laboratory, Stanford. 
All these cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS, 
Invitrogen) and in a 5% CO2 incubator at 37 ºC. 
2.6 Transient expression  
Transient transfection was done in 6-well plates for the indirect immunofluorescence 
microscopy, or in 10-cm plates for immunoprecipitation and immunoblotting 
experiments. The cells were transfected using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s protocol. For 6-well plates, 4 µg DNA and 10 µl 
Lipofectamine 2000 were diluted in 0.8 ml Opti-MEM (Invitrogen), respectively, and 
separately incubated for 5 min at room temperature. The 2 solutions were then mixed 
and incubated for 25 min at room temperature. The DNA-Lipofectamine complexes 
were added to 6-well plates with 2 ml fresh medium. The cells were tested for 
transgene expression after 24 hours.  
For 10-cm plates, Lipofectamine 2000, DNA and Opti-MEM were increased in 




immunoprecipitation experiments or immunofluorescence analysis 24-48 hr post-
transfection. 
2.7 SDS-PAGE  
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) was performed according to 
the method of Laemmli (Laemmli, 1970). Discontinuous SDS-PAGE with a stacking 
gel (pH6.8, 0.125 M Tris-HCl, 0.1% SDS and 3.9% acrylamide) and separating gel 
(pH 8.8, 0.375 M Tris-HCl, 0.1% SDS and 7-12% acrylamide) were conducted in 1 
×SDS Running Buffer (25 mM Tris Base, 250 mM glycine, 0.1% SDS) at 160 volts 
(constant voltage). 
2.8 Coomassie blue staining 
Gels were stained in staining solution (0.25% Coomassie Brilliant Blue R-250(Bio-
Rad), 50% methanol and 10% acetic acid) for 20 min with gentle agitation then 
destained in destaining solution (50% methanol and 10% acetic acid). Replenish the 
solution several times until background of the gel is fully destained. 
2.9 Immunoprecipitation and Western blot 
Cells were lysed in lysis buffer, containing 20 mM Tris-HCl (pH7.4), 150 mM NaCl, 
0.5% Triton X-100, complete EDTA-free protease inhibitor mixture (Roche, Nutley, 
NJ,USA), 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate and 50 mM 
NaF. The cell lysates were centrifuged at 16,000Xg for 30 min at 4 ºC, and the 
supernatant was collected for immunoprecipitation experiments or Western blotting. 
For immunoprecipitation, the supernatant was incubated with 40 µl of 50% c-Myc 
Monoclonal Antibody-Linked Agarose Beads (Clontech) for 12 hr at 4 ºC. The beads 




buffer for 5 min at 95ºC. After being resolved by SDS-PAGE gels, proteins were 
transformed onto nitrocellulose membranes. These membranes were blocked by 3% 
milk in PBS/Tween 20 (PBST) buffer (PBS with 0.05% Tween-20) for 1 hr at room 
temperature, then incubate with primary antibody in 3% milk/PBST for 1 hr at room 
temperature followed by 3 times washing with PBST (10 min each time). The 
membranes were then incubated with secondary antibody (Jackson ImmunoResearch) 
in 3% milk/PBST, and washed 3 times with PBST (10 minu each time). Specific 
protein bands were visualized by the SuperSignal West Pico Chemiluminescence 
Substrate (Pierce). Protein loading was assessed by detection for β-actin.  
Fresh tissues were homogenized in a modified RIPA buffer (50 mM Tris-HCl [pH 
7.5], 150 mM NaCl, 5 mM EDTA, 2 mM DTT, 1% deoxycholic acid, 1% Triton X-
100, 0.1% SDS, 1 mM PMSF and complete EDTA-free protease inhibitor mixture 
from Roche Diagnostics). Proteins were transferred onto Hybond-C extra membranes 
(Amersham) after being separated by SDS-PAGE gels. Protein identities were 
determined with specific primary antibodies and appropriate peroxidase-conjugated 
secondary antibodies (Jackson ImmunoResearch Laboratories). Peroxidase activity 
was detected with the SuperSignal substrate and enhancer (Pierce) and visualized on 
X-ray films. Quantitative analysis was carried out with a GS-800 calibrated 
densitometer from Bio-Rad (Hercules, CA, USA). 
2.10 Indirect immunoflurescence microscopy 
Cells grown on coverslips were washed 3 times with PBSCM (PBS containing 1 mM 
CaCl2 and 1 mM MgCl2), then fixed with 3% paraformaldehyde (PFA) in PBSCM for 
20 min at room temperature. After washing twice with 50 mM NH4Cl in PBSCM for 




PBSCM for 5 minat room temperature. The cells were incubated with primary 
antibody in fluorescence dilution buffer (PBSCM with 5% normal goat serum, 5% 
fetal bovine serum and 2% bovine serum albumin, pH7.6) for 60 min at room 
temperature, followed by washing with PBSCM, and incubated with secondary 
antibodies for 1 hr at room temperature. After washing, the coverslips were mounted 
with Vectashield (Vector Laboratiories, Burlingame, CA, USA) and sealed by nail 
varnish. Cells were viewed and the images were taken by using a confocal laser 
scanning microscope (Zeiss LSM510 Meta (Carl Zeiss) and MRC1024 (Bio-Rad)). 
2.11 Protein/lipid overlay assay 
PIP-StripsTM strips were purchased from Echelon, Inc. (Salt Lake City, UT). The 
strips were blocked with 3% bovine serum albumin (BSA) in 10 mM Tris/HCl, pH 8.0, 
150 mM NaCl and 0.1% (v/v) Tween 20 (Tris-buffered saline) for 4 hr. Membranes 
were incubated overnight at 4 °C with 1 µg/ml of the relevant GST fusion protein in 
the blocking solution, after which the membranes were washed 12 times for 5 min 
with Tris-buffered saline. For detection of bound protein, the membranes were 
incubated with goat anti-GST polyclonal antibody, washed 6 times for 5 min with 
Tris-buffered saline, then incubated with rabbit anti-goat antibody conjugated with 
horseradish peroxidase, and finally washed again prior to being visualized using 
SuperSignal West Pico Chemiluminescence Substrate. 
2.12 Short hairpin RNA-mediated knockdown of SNX27 
 Short hairpin RNAs (shRNA) against human SNX27 were designed using a small 
interfering RNA design program from Ambion (Foster City, CA,  
USA) and subcloned into the BglII/XhoI sites of the pSuper.Retro.puro vector 




A431 cells and Western blot analysis of total cell lysates with the anti-SNX27 
antibody. The sequences for the sense oligonucleotides for the knockdown construct 
were:  
shRNA735, 5’- AGT GTG TTC AAT ACG AGT A -3’;  
shRNA878, 5’- AGA ACA GTA CTA CAG ACC A -3’;  
shRNA920, 5’- AGG TTG GCA TGG ACA GTA C -3’. 
The sequence for the sense oligonucleotides for the scramble control construct is: 
5’- AAG TCG GTG TGC TCT TGT TGG-3’.  
2.13 Retroviral infection 
For retroviral infection, Phoenix-Ampho cells (packing cell for human cell infection) 
were transfected with retroviral vectors using Lipofectamine 2000 (Invitrogen), 
according to the manufacturer’s instruction. The supernatant was recovered and used 
to infect the A431 cells (protocols from Nolan laboratory, University of Stanford, 
USA). The details are described: On day 1, Phoenix-Ampho or Phoenix-Eco cells 
were plated onto 10-cm plate and grown to 70% confluence. The Phoenix cells were 
then transfected by Lipofectamine 24 hours later. Medium was changed to fresh 
complete DMEM (10ml) and the cells were left at 32ºC on day 3. At the same time, 
the target cells were split and plated into 6-well plates. On day 4, the supernatant was 
harvested from the packing cells and centrifuged for 5 min at 1000Xg, then filtered 
through 0.45 μm filter, and the viral supernatant was concentrated by centrifugation at 
16,000Xg for 4 hr, the viral pellet was resuspended in fresh medium by gentle 
pipetting. After moving medium from the target cells, 2 ml of the filtered supernatant 
was added to the target cells with 5 µg/ml polybrene, the cells were placed at 32ºC 
with gentle shaking. The remaining virus supernatant was kept at 4ºC. On day 5, the 




DMEM and placed at 37ºC for at least 8 hr. The retroviral infection was repeated 2 
more times and selected with puromycin (1µg/ml) for 1 week and assessed for the 
expression level of the target protein. 
 
2.14 EGF internalization 
For Rhodamine-conjugated EGF internalization 
A431 cells were starved overnight in DMEM containing 50 mM HEPES and 1% BSA 
before being incubated with 20 ng/ml of Rhodamine-conjugated EGF (EGF-Rho, 
Invitrogen) for 60 min at 4 ºC. The cells were then washed 3 times with DMEM 
containing 50 mM HEPES and 1% BSA. After internalization for 0 or 3 hr in DMEM 
containing 10% serum at 37 ºC, the cells were washed 3 times with ice-cold PBS and 
then fixed by 3% paraformaldehyde-PBSCM for indirect immunofluorescence 
microscopy. 
For live cell imaging 
A431 cells were incubated with 20 ng/ml of oregon green 488 labeled EGF (OG-EGF, 
Invitrogen) on ice for 60 min to allow binding of OG-EGF to EGFR on the cell 
surface. After extensive washing to remove excess/unbound OG-EGF, cells were 
incubated at 37 ºC for 60 min to allow the internalization and delivery of OG-EGF to 
the late endosome/lysosome. Surface and intracellular fluorescent vesicles were 
visualized on Olympus Fluoview inverted microscope. Images were acquired one 
frame/min, using 60X Apochromat objectives. The number of endocytosed vesicle in 
each cell was analyzed using Cell-P-Software by Olympus. 




A431 cells were serum-starved in DMEM with 0.1% FBS for 16 hr, and washed once 
by starvation medium, then incubated with EGF (Upstate Biotechnology) at a final 
concentration of 100 ng/ml at 37 ºC for different times. After stimulation, the cells 
were washed once with cold PBS, then were lysed in lysis buffer containing 25 mM 
Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% Triton X-100, Complete EDTA-free protease 
inhibitor mixture, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 50 
mM NaF. The cell lysates were centrifuged at 16,000Xg for 30 min at 4ºC, and the 
supernatant was collected for Western blot.  
Results of EGFR degradation from Western blots were quantified by densitometry 
using Quantity One software (Bio-Rad). 
2.16 Cell surface biotinylation and stripping 
Cells grown on 10-cm dishes to 90-95% confluence were washed with ice-cold 
PBSCM and then incubated with 10 ml of 1.5 mg/ml fresh sulfo-NHS-SS-biotin for 
30 min at 4ºC. The unreacted biotin was quenched twice with cold 50 mM glycine in 
PBSCM at 4ºC. Cells were then supplied with fresh DMEM containing 100 ng/ml of 
EGF, and were incubated either at 4ºC to block membrane trafficking (negative 
control) or at 37ºC for various times to allow endocytosis to occur. After endocytosis, 
cells were subjected to 2X incubations (15 min each) with glutathione cleavage buffer 
(50 mM glutathione in 75 mM NaCl, 10 mM EDTA containing 1% BSA, 0.075 M 
NaOH) at 4ºC to cleave off the biotin attached to the surface exposed proteins. 
Unreacted glutathione was quenched twice (5 min each) at 4 ºC with 5 mg/ml of 
iodoacetamide in PBSCM. Cell lysates were incubated with Immobilized Neutr 




were resolved by SDS-PAGE and analyzed by immunoblotting. All immunoblotting 
results were quantified by densitometry using the Quantity One software (Bio-Rad). 
2.17 Yeast two-hybrid assays 
Gal4 based yeast two-hybrid screening 
The yeast two-hybrid screens were done according to protocols provided by Clontech. 
The Gal4-DNA binding domain fused SNX27aFL in pGBKT7 was used to transform 
the yeast strain Y187 (BD Clontech). The resulting transformed AH109 yeast cells 
were mated with Gal4-DNA activating domain (Gal4-AD) fused Human brain 
Pretransformed Matchmaker cDNA library in AH109 yeast cells (BD Clontech). The 
interaction positive diploid yeast cells were selected on the highest stringency using 
SD/-Trp/-Leu/-His/-Ade (QDO) plates. The Gal4-AD fused cDNA was extracted 
from those positive clones and subsequently sequenced. Those partial sequences were 
subjected to BLAST (Basic Local Alignment Search Tool) search at NCBI (National 
Center for Biotechnology and Information) website to identify the corresponding 
cDNAs. 
Yeast two-hybrid assays for confirming protein-protein interactions 
The SNX27 bait vector in pGBKT7 and isolated prey vectors were transformed into 
Y187 and AH109 yeast cells, respectively. Transformed AH109 and Y187 yeast cells 
were mated and the resulting diploid yeast cells containing DNA-BD and DNA-AD 
fusion constructs were selected on SD/-Trp/-Leu medium for 2 days. Then the cells 
were plated on the SD/-Trp/-Leu/-His/-Ade (QDO) plate to test for protein–protein 
interaction. 




 The coding region of mouse SNX27 is derived from 11 exons with the third coding 
exon encoding amino acids 179-243, which form the major part of the PX domain 
(residues 160-265) that is crucial for SNX27 to be targeted to the early endosome. A 
SNX27 gene targeting construct was created by inserting the Neo-cassette into this 
coding exon. A SalI site was first introduced into this exon by site-directed 
mutagenesis and a targeting vector was generated by inserting the Neo-cassette into 
this site with an 8 kb right arm and a 4 kb left arm flanking the insertion. The 
targeting vector pBluescript SK+ (Stratagene, Cedar Creek, TX, USA) was linarized 
and the targeting construct was transfected into embryonic stem cells (E-14) via 
electroporation followed by G418 (CALBIOCHEM) selection. After 7-9 days under 
selection, the surviving colonies were picked and screened by long-range PCR. The 
correctly targeted ES cells were used for blastocyst microinjection. Chimeras were 
used for crossing with Sv129 females to obtain F1 generation. Crosses between F1 
mice gave rise to wild-type (SNX27+/+), heterozygous knockout (SNX27+/-) and 
homozygous knockout (SNX27-/-) mice as assessed by PCR-based method. 
2.19 Mouse genotyping 
1). Primers for SNX27 ES cell genotyping:  
RT-01: 5’- TGA GTG CTG GGA TTA AAG GCA TGC-3’;  
RT-neo: 5’- CCA TCT TGT TCA ATG GCC GAT CC -3’. 
PCR program:  
95°C 15min 
94°C 30 sec 
58°C 40 sec             30 cycles 




72°C 10 min 
 
 
2). Primers for SNX27 mouse tail DNA extraction genotyping: 
KO01:  5`-AGA AAT GAA GCA TCG CTT ACC C-3’; 
KO02:  5'- GTT CCT GTC TCA CCA GGT ATA C-3’; 
KOneo: 5`-GGC CGC TTT TCT GGA TTC ATC G -3’. 
 
PCR program:  
95°C 15min 
94°C 30 sec 
55°C 40 sec             30 cycles 
72°C 40 sec 
72°C 10 min 
PCR reaction was carried out using Qiagen HotStar Taq Master Mix Kit, giving rise 
to a 300bp band for neomycin gene and a 200 bp band for SNX27 gene, 
2.20 DNA extraction  
ES cell DNA extraction with phenol chloroform  
 
a. Transfer the samples to a polypropylene tube and add an equal volume of 
phenol:chloroform: isoamyl alcohol (25:24:1; v/v/v).  
 
b. Mix the contents of the tube until an emulsion forms.  
 
c. Centrifuge the mixture at 16,000Xg for 5 min at 4°C.  
 
PCR reaction was carried out using Advantage 2 polymerase, giving rise to a 2000bp 




d. Transfer the aqueous phase to a fresh tube. Discard the interface and the organic 
phase.  
 
e. Add 2.5 X volume of 95% cold alcohol, 1/10 X volume of 3M NaAc (pH5.3), 
vortex thoroughly.  
 
f. Spin the tubes in a microcentrifuge at 16,000Xg for 5 min at 4°C.  
 
g. Remove the supernatant, carefully overlay the pellet with 400 μl of 70% ethanol.  
 
h. Spin down at 16,000Xg for 2 min at room temperature.  
i. Aspirate the supernatant. Dry the pellet for 15 min at room temperature by air to 
evaporate the residual ethanol.  
 
j. Dissolve the pellet in sterile TE buffer or dH2O.  
 
Mouse tail DNA extraction 
Mouse tail sample was collected into 1.5 ml eppendorf tube and added 500 μl of tail 
lysis buffer (50 mM Tris, pH8.0, 100 mM NaCl, 100 mM EDTA, 1% SDS) with 40 μl 
of proteinase K (10 mg/ml in stock), and shaked overnight at 55 ºC. On the next day, 
top it up with 170 μl of saturated NaCl and rock for 5 min. Then spin down in bench 
centrifuge at 16,000Xg for 20 min. Transfer the supernatant into a new tube and add 
in 500 μl of isopropanol, invert the tube to get precipitation and spin down at top 
speed for 12 min to obtain DNA pellet. Wash the pellet with 300 μl of 70% ethanol; 
spin down at top speed for 7 min. Suck out the liquid and dry the pellet till transparent, 
then dissolve it in TE buffer or H2O. 
2.21 Histological analysis and immuno-staining  
Mice were sacrificed and tissues were harvested and fixed in freshly prepared 4% 
paraformaldehyde-PBS (pH 7.5), followed by routine dehydration process and wax 
embedding before being sectioned into 3µm thickness for Hematoxylin & Eosin 




For immuno-staining, the samples were fixed in Tissue-Tek® O.C.T. compound 
(Sakura Finetek, Torrance, CA, USA) on dry ice/ethanol and sectioned at -20ºC. The 
sections were fixed in 4% paraformaldehyde-PBS for 30 min, washed 3 times with 
0.2% Triton-PBS (5min each), blocked with 4% BSA/10% FBS-PBS for 60 min at 
room temperature, and incubated with primary antibody diluted in blocking buffer at 
4ºC for overnight, followed by washing 3 times (5 min each) with 0.1% Triton-PBS 
and FITC/Texas Red conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories) incubation in washing buffer for 1 hr at room temperature. The samples 
were then washed 3 times (5 min each) with PBS and mounted onto slide in 
VECTASHIELD Mounting Medium (Vector Laboratories) for fluorescence 
microscopy. Nuclei were stained with DAPI or TO-PRO-3 (Molecular Probes, 
Carlsbad, CA, USA). 
2.22 Tissue immunoblot analysis 
Fresh tissues were homogenized in a modified RIPA buffer for 30 min. Proteins were 
transferred onto Hybond-C extra membranes (Amersham) after being separated by 
SDS-PAGE gels. Protein identities were determined with specific primary antibodies 
and appropriate secondary antibodies (Jackson ImmunoResearch Laboratories). 
Peroxidase activity was detected with the SuperSignal substrate and enhancer (Pierce) 
and visualized on X-ray films. 
Quantitative analysis was carried out with a GS-800 calibrated densitometer from 
Bio-Rad. 




Urine samples were collected by placing mice on a wire mesh platform in clean 
metabolic cages and giving free access to food and water. 24-hour urine output was 
collected and water consumption was measured. Urine chemistries were measured by 
the National University Hospital of Singapore.  
Blood samples were collected from mouse tail vain. Blood glucose level was 
measured immediately using the Roche, Advantage II quick test machine. 
2.24 Isolation and culture of mouse collecting duct cells  
We developed a new method for purifying and culturing mouse collecting duct cells, 
based on previously described ones for rat cells (Stokes et al., 1987; Maric et al., 
1998; Hasler et al., 2002). Mouse kidneys were minced into small pieces with a pair 
of fine scissors. The tissue fragments were washed three times with PBS before being 
digested at 37oC for 90-120 min with 0.2% hyaluronidase (Sigma, H3884) and 0.2% 
collagenase P (Roche applied science) in a hypertonic PBS supplemented with 1 mM 
CaCl2, 1 mM MgCl2, 11 mM glucose and 150 mM NaCl (~ 1 ml solution per kidney). 
Cells were dispersed by vigorous pipetting in the middle and at the end of the 
digestion. The suspension was then diluted 5 times with PBS and spun for 5 min at 
25Xg on a GS-6R BECKMAN centrifuge. The pellet was resuspended and 
centrifuged two more times at 6Xg for 5 min. The pellet was resuspended and loaded 
on top of a layer of 20% Percoll (Sigma) that was in turn laid on a layer of 35% 
Percoll. After a spinning at 600Xg for 15 min, a band at the 20-35% Percoll interface 
was recovered and washed with PBS. The purified collecting duct cells were cultured 
in a hypertonic DMEM (2-3 ml per kidney) that was supplemented with 2 mM L-




antibiotics. The osmolality of the DMEM was adjusted to 600 mOsm with additional 
100 mM NaCl and 100 mM urea.  
2.25 Hippocampal cultures and transfection 
Brains are isolated from PN1 (postnatal day 1) Sprague–Dawley rat pups. Cells were 
dissociated in 0.25% trypsin and incubated with 0.01% DNase Solution (Sigma. D-
5025). Dispersed hippocampal neurons were plated onto polyornithine/fibronectin 
coated glass coverslips at a density of 200,000 or 350,000 cells per well of a 24-well 
dish. The neurons were grown in DMEM/F12, containing 10% fetal bovine serum and 
B-27  supplements (Gibco). After 3 days in culture, 3 μM cytosine arabinoside was 
added to inhibit proliferation of non-neuronal cells. The cultures were maintained in a 
5% CO2 incubator until transfection was performed and cells were then processed for 
immunofluorescence.  
Hippocampal neurons (3–5 day) were transfected using Lipofectamine 2000 
(Invitrogen) according to manufacturer’s protocol. After transfection, the cells were 
returned to conditioned medium and maintained at 37°C in a 5% CO2 incubator.  
2.26 Apoptosis assay 
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling 
(TUNEL) assays were performed on cryosections of mouse kidney sections with a 










CHAPTER 3: CELL BIOLOGICAL CHARACTERIZATION OF SNX27 
3.1 Identification of SNX27 and gene cloning 
SNX27 was identified through a Blast search of the NCBI human EST database for 
proteins homologous to the protein sequence of the SNX1-PX domain. SNX27 has 
two isoforms: SNX27a (with 541 amino acids in length) and SNX27b (with 528 
amino acids in length). The only difference is the C-terminal 15 amino acid sequence 
(NIFQMARSQQRDVAT) of SNX27a is replaced by two other residues (EY) in 
SNX27b (Fig. 3.1A). They both contain a PDZ (Psd-95/Dlg/ZO1) domain (aa 40-136), 
followed by a PX domain (aa 160-265) and then a RA (Ras Association) domain (aa 
271-362). 
The coding regions of both isoforms of SNX27 were amplified by PCR from a human 
Universal Quick Clone cDNA library (Clontech) using Advantage 2 polymerase and 
specific primers for the common 5’ end (5’-
ATGGCGGACGAGGACGGGGAAGGGATT) and the specific 3’ end of SNX27a 
(5’-CTAGGTGGCCACATCTCTCTGCTGTGACCT) and SNX27b (5’-
CTAATATTCCTCTTTTCTCCACTTGAGCTC). A 5’ XhoI site and a 3’NotI site 
were introduced during PCR amplification. Both SNX27a and SNX27b were 
subcloned into pDMyc-Neo and pDHA-Neo vectors using the XhoI and NotI sites. 
3.2 SNX27 is targeted to the early endosome 
To investigate the cellular distribution of SNX27, we performed immunofluorescence 
microscopy on cells expressing Myc-tagged SNX27. A431 cells expressing Myc-
SNX27 were fixed, permeabilized and labeled with polyclonal anti-Myc and 




well with the early endosome marker EEA1. This result suggests that, like SNX1 and 
SNX3, SNX27 is targeted to the early endosome. 
3.3 The PX domain is required for endosomal localization of SNX27 
The PX domain has previously been shown to be critical for the cellular localization 
of SNX3 and SNX16 (Xu et al., 2001a; Hanson and Hong, 2003). To determine 
whether the PX domain is necessary for the intracellular localization of SNX27, we 
made a series of expression constructs for expressing truncated forms of the protein. 
Truncated mutants, Myc-SNX27a∆PDZ, Myc-SNX27a∆PX, Myc-SNX27NT and 
Myc-SNX27aCT, were generated through standard method and these deletion mutants 
were depicted in Fig. 3.3A. A431 cells expressing wild-type SNX27a and these 
mutants were fixed, permeabilized and labeled with polyclonal anti-Myc. As expected, 
deletion of the PX domain of SNX27a abolished its membrane association, resulting 
in cytosolic distribution (Fig. 3.3B). In contrast, deletion of the PDZ domain or C-
terminal region did not have major effect on the endosomal association of SNX27a, as 
the patterns of immunofluorescence staining observed for SNX27a∆PDZ and 
SNX27NT were similar to that of the full-length protein. The results suggest that the 













Fig. 3.1: SNX27 as a new member of the SNX family. (A), Domain organization. 
SNX27 contains three domains, the PDZ, PX and RA domain, and exists in two 
isoforms. (B), Alignment of human SNX27a, human SNX27b, mouse and rat 













Fig. 3.2: Myc-SNX27a co-localizes with EEA1. A431 cells were transfected to 
express Myc-SNX27a and processed for indirect immunofluorescence using a 
rabbit polyclonal antibody against Myc (revealed by a goat polyclonal anti-body 
against rabbit IgG conjugated to FITC) (a), and a mouse monoclonal antibody 
against EEA1 (revealed by a goat polyclonal antibody against mouse IgG 
conjugated to AlexaFluor 555) (b). The presence of yellow staining indicates 
overlap in the merged pictures (c). Bar: 10 μm. 
Fig. 3.3: The PX domain is required for endosomal localization of SNX27. 
(A), Diagrammatic representation of the SNX27a deletion mutants. (B), A431 
cells expressing Myc-tagged SNX27a and its mutants were processed for 
indirect immunofluorescence microscopy with rabbit polyclonal antibody 
against Myc (visualized with goat polyclonal antibody against rabbit IgG 





3.4 The PX domain mediates direct interaction with PI(3)P 
The PX domain is capable of interacting with PI(3)P and targeting the host protein to 
the early endosome (Worby and Dixon, 2002; Cullen, 2008). We next examined 
whether SNX27 is capable of binding to any of the phosphorylated lipids. The 
protein/lipid overlay assay involves probing strips of nitrocellulose spotted with 
various lipids with potential target molecules. Since SNX16 has been shown to bind 
to PI(3)P (Hanson and Hong, 2003), GST-SNX16 was used as a positive control. As 
shown in Fig. 3.4, recombinant GST-SNX16 bound exclusively to PI(3)P in 
agreement with the previous report. We next tested the ability of SNX27a full-length 
and SNX27-PX in interacting with the lipids.  
It is shown in Fig. 3.4B that full-length recombinant SNX27a significantly recognized 
PI(3)P and a weak signal was also detected with PA (phosphatidic acid). No 
detectable binding was seen for PIs that phosphorylated at other positions (PI(4)P and 
PI(5)P), for the bis-phosphorylated PIs (PI(3,4)P2, PI(3,5)P2 and PI(4,5)P2) or for the 
tris-phosphorylated PI (PI(3,4,5)P3). Similarly no binding was found for other lipids 
tested: lysophosphatidic acid, lysophosphatidylcholine, phosphatidylethanolamine, 
phosphate-dylcholine, sphingosine 1-phosphate and phosphatidylserine. When the PX 
domain of SNX27 alone was used in this assay, besides the binding to PI(3)P and PA, 
a small amount of binding was also seen for PI(3,4)P2  and PI(5)P (Fig. 3.4B). These 
results suggest that SNX27 preferentially binds to PI(3)P through the PX domain and 











Fig. 3.4: SNX27 preferentially binds to PI(3)P. (A), Diagrammatic representation of 
the SNX16, SNX27a and SNX27PX used for the lipid binding. CC, coiled-coil domain. 
(B), GST-SNX16, GST-SNX27a or GST-SNX27PX was incubated with nitrocellulose 
spotted with the indicated lipids. Bound protein was detected using a GST-specific 
antibody. LPA, lysophosphatidic acid; LPC, lysophosphatidylcholine; 
PE,phosphatidylethanolamine; PC, phosphatidylcholine; SIP, sphingosine1-phosphate; 
PI, phosphatidylinositol; PA, phosphatidic acid; PS, phosphatidylserine. 
Fig. 3.5: Characterization of polyclonal anti-SNX27 antibody. The rabbit 
antibodies after 4th antigen injection were purified and used at 0.1g/ml to probe the 
membrane blot containing 50 µg A431 cell lysates (lanes 1, 2 and 3). The anti-
SNX27 antibodies recognized a polypeptide of ~60 kDa (lane 1). The antibodies were 
blocked using the antigen GST-SNX27NT on lane 2 and control GST-SNX16FL on 










3.5 Generation of rabbit anti-SNX27 polyclonal antibody and characterization of 
endogenous SNX27  
To study the biochemical properties of SNX27, a good antibody is crucial. We used 
recombinant glutathione S-transferase (GST)–SNX27NT (aa 1-266) to raise SNX27-
specific antibody in rabbits. The antibodies were affinity purified by GST-SNX27NT 
conjugated column and tested by Western blot analysis. The endogenous proteins in 
A431 cells recognized by the anti-SNX27 antibody corresponded to a polypeptide of 
~60 kDa (Fig. 3.5, lane 1). However, when the antibodies were firstly incubated with 
GST-SNX27NT, this 60 kDa band was no longer detected (Fig. 3.5, lane 2), while 
prior incubation of the antibodies with GST-SNX16FL did not affect the detection of 
this band (Fig. 3.5, lane 3), suggesting that the 60 kDa band represents endogenous 
SNX27 and the antibodies are specific for SNX27. 
With the SNX27-specific antibodies, we next examined the expression of SNX27 in 
various cell lines by immunoblotting analysis (Fig. 3.6). Various cell lines were 
harvested and lysed in RIPA buffer. The protein concentration was measured by Bio-
Rad Protein Assay, and 40 µg cell lysates were loaded in each well. Fig. 3.6 showed 
that the anti-SNX27 antibodies detected a ~60kDa band in human (A431, HeLa and 
HEK293T), monkey (COS7), rat (NRK) and mouse (PC12, ATT20 and MIN6) cell 
lines. These results also suggest that SNX27 is widely expressed in cell lines derived 













3.6 Endogenous SNX27 is preferentially localized to the early endosome  
To corroborate the conclusion that SNX27 is targeted to the early endosome in a PX-
domain dependent manner based on analysis of epitope-tagged SNX27 and its 
mutants, we have next examined the sub-cellular localization of endogenous SNX27 
by indirect immunofluorescence microscopy using the SNX27-specific antibodies. 
Since vesicular endosome-like labeling of endogenous SNX27 was observed in 
essentially all cell lines, we have thus performed double-labeling of SNX27 in A431 
Fig. 3.6: SNX27 is widely expressed in cell lines derived from a variety of 
species. Affinity-purified anti-SNX27 antibodies were used at 0.1 µg/ml to probe 
immunoblot containing 40 µg of lysates prepared from the indicated tissue 
cultured cells of human (lanes 1, 2, 3 and 4), monkey (lane 5), rat (lane 6) and 
mouse (lanes 7, 8 and 9) origin. The antibodies detected a band of ~60 kDa in 
these samples. The immunoblot was also probed with an antibody against β-actin 
as a loading control. 
 




cells with various organelle markers, including early endosomal marker EEA1, late 
endosomal marker LAMP2 and Golgi marker GS28. We found that SNX27 co-
localized best with EEA1 (Fig. 3.7, a–c), but not with LAMP2 or GS28, confirming 
that endogenous SNX27 is primarily associated with the early endosome.  
3.7 Endosomal association of SNX27 is dependent on PI 3-kinase activity  
Since the PX domain of SNX27 is capable of interacting with PI(3)P and is essential 
for endosome targeting, it is most likely that PX-domain mediated interaction with 
PI(3)P is the mechanism responsible for SNX27 to associate with the early endosome. 
PI 3-kinase inhibitors such as Wortmannin can inactivate the activity of several types 
of PI 3-kinases and thus reduce the level of endosomal PI(3)P (Vanhaesebroeck et al., 
1997; Rameh and Cantley, 1999). Wortmannin was used to validate PI(3)P-dependent 
endosomal association of FYVE- or PX-domain proteins such as EEA1, SNX3 and 
SNX16 (Patki et al., 1997; Xu et al., 2001a; Choi et al., 2004). To test the effect of 
Wortmannin on SNX27 localization, we treated A431 cells with this drug followed by 
immunofluorescence detection with both anti-SNX27 and anti-EEA1 antibodies. 
Unlike control cells in which SNX27 and EEA1 co-localized in the vesicular early 
endosome (Fig. 3.8, a and b), endosomal localization of SNX27 and EEA1 was 
significantly reduced with concomitant increase of cytoplasmic labeling (Fig. 3.8, c 
and d). These results suggest that endosomal association of SNX27 is dependent on 
the continues generation of PI(3)P by the PI 3-kinases.  
Taken together, our results suggest that the PX domain of SNX27 mediates its early 










Fig. 3.7: SNX27 co-localizes with EEA1. A431 cells were fixed and processed for 
indirect immunofluorescence using rabbit polyclonal antibodies against SNX27 (revealed 
by a goat polyclonal antibody against rabbit IgG conjugated to FITC) (a, e and i), mouse 
monoclonal antibodies against EEA1 (b), Golgi protein GS28 (f) and LAMP2 (j) (b, f and 
j are revealed by a goat polyclonal antibody against mouse IgG conjugated to AlexaFluor 
555). The presence of yellow staining indicates overlap in the merged pictures (d, h and l). 
Bar: 10 µm. 
a                                b                                 c                                  d 
 e                                 f                                  g                                  h 
i                                  j                                k                                   l 
Fig. 3.8: Wortmannin-sensitive endosomal association of SNX27. A431 cells were 
cultured in the absence of serum for 3 hr followed by treatment with (c, d) or without (a, 
b) Wortmannin (25 nM) for 15 min. Cells were then fixed and processed for the 
simultaneous detection of SNX27 (a, c) and EEA1 (b, d) by indirect immunofluorescence 
microscopy. Like EEA1, SNX27 was redistributed from endosomal membranes to the 





3.8 SNX27 tissue expression pattern  
It has been shown previously that the rat SNX27a mRNA was highly expressed in the 
testis and various rat brain areas (Kajii et al., 2003; Lunn et al., 2007). However, the 
expression of SNX27 in tissues has not been studied at the protein level. Since our 
polyclonal antibodies can recognize the rat and mouse SNX27, we next examined 
SNX27 expression in several mouse tissues (Fig. 3.9). Lysates from the indicated 
mouse tissues were prepared by homogenization of 1g of the appropriate organ in 4 
ml of RIPA buffer with 25 strokes of a drill fitted Teflon glass homogenizer. The 
homogenates were centrifuged at 16,000Xg for 30 min at 4°C and the resulting 
supernatants were resolved on 10% SDS-PAGE prior to transfer to nitrocellulose 
membrane for immunoblotting. Analysis of the tissue expression of SNX27 indicated 
that it was expressed in all tissues at various levels (Fig. 3.9).  
Beyond this, we examined the SNX27 tissue expression pattern in cyrosections using 
immunohistology. The fresh-frozen tissues from adult mouse were sectioned into 10 
µm thick cyrosections and stained with anti-SNX27 antibodies, and a non-specific 
rabbit IgG was used as negative control. As shown in Fig. 3.10, in the brain section, 
SNX27 was particularly enriched in neuron cells. In the pancreatic section, SNX27 
was mainly detected in exocrine cells. In the lung section, SNX27 was highly 
expressed in the basal cells of bronchioles.  
The wide expression of SNX27 in different cell lines and various tissues indicates that 











Fig. 3.9: SNX27 is expressed in multiple mouse tissues. The affinity-purified rabbit 
polyclonal anti-SNX27 antibodies were used to probe immunoblot containing 40 µg of 
lysates prepared from the indicated mouse tissues. The antibody detected a band of ~60 
kDa in all tissues at various levels. The immunoblot was also probed with an antibody 














Fig. 3.10: Detection of SNX27 protein expression in mouse tissue samples by indirect 
immunofluorescence. The experiments were performed using anti-SNX27 antibodies (a, b 
and c) on cyrosections derived from fresh-frozen mouse tissues (revealed by a goat 
polyclonal antibody against rabbit IgG conjugated to FITC). The non-specific rabbit IgG 
was used as the negative control (a’, b’ and c’). SNX27 positive cells in the brain (a), 







Sorting nexins (SNXs) are characterized by a conserved lipid binding domain known 
as the SNX-PX domain and involved in various aspects of endosomal trafficking and 
receptor targeting (Worby and Dixon, 2002; Seet and Hong, 2006; Cullen, 2008). For 
example, the first identified sorting nexin, SNX1, was found to associate with EGFR 
kinase domain and function in regulating the late endosome/lysosomal trafficking of 
EGFR (Kurten et al., 1996). In addition, SNX3 actively promotes the transport of 
transferrin receptor from the early to the recycling endosomes (Xu et al., 2001a). In 
this chapter, we described the cell biological and biochemical characterizations of a 
newly identified member of SNX family, SNX27.  
First of all, we showed that SNX27 is associated with the early endosome by 
immunofluoresce labeling. The PX domain is necessary for endosomal targeting of 
SNX27. A number of PX domain proteins, including sorting nexins, have been shown 
to bind phosphoinositides via the PX domain (Ellson et al., 2001; Xu et al., 2001a; 
Lemmon, 2003). For example, the PX domain of SNX1 not only binds to PI(3)P but 
also PI(3,5)P2 in liposome-based assays (Cozier et al., 2002). In another case, the 
SNX16-PX domain interacts with PI(3)P and PI(3,4)P2 in the protein/lipid overlay 
assay (Hanson and Hong, 2003). In our study, we have shown here that the isolated 
PX domain of SNX27 and full-length SNX27 strongly bound to PI(3)P in 
protein/lipid overlay assay. These results suggest that the function of the SNX27-PX 
domain is to target SNX27 to the early endosome via association with PI(3)P.  
Secondly, we have demonstrated that the endosomal localization of SNX27 is also 
dependent upon PI 3-kinase activity. When cells were treated with Wortmannin, a 





Lastly, a purpose of this study is to evaluate the SNX27 expression in tissues. 
Previous studies have reported SNX27 mRNA expression in the rat brain and testis 
(Kajii et al., 2003; Lunn et al., 2007). Using the specific anti-SNX27 antibodies 
generated and characterized here, we investigated the tissue distribution of SNX27 
protein. Western blot analysis showed constitutive SNX27 expression in the brain, 
lung, liver, pancreas, spleen, kidney and testis. Immunofluorescence microscopy 
analysis using mouse tissue sections showed SNX27 is expressed in specific regions. 
Consistently, SNX27 is widely expressed in many cell lines derived from several 
species. 
SNX27 contains multiple protein-protein and protein-lipid interaction domains, 
including the PDZ domain, the PX domain and the RA domain, suggesting it could 
play versatile roles inside the cell. The observations of sub-cellular localization and 
basic biochemical characterizations of the SNX27 promoted us to study its role in 
protein trafficking and physiological processes in mice.SNX27 has two isoforms 
SNX27a and SNX27b. The only difference between SNX27a and SNX27b is the last 
15 amino acid. The GST-SNX27NT which is the antigen used for generating of anti-
SNX27 antibody was shared by both SNX27a and SNX27b. SNX27a and SNX27b 
could not be distinguished by the anti-SNX27 antibody. To study the protein 
expression of any individual isoform of SNX27, specific antibody should be raised 






CHAPTER 4: FUNCTIONAL CHARACTERIZATION OF SNX27 USING 
                        KNOCKOUT MICE000000000000000000000000000000000 
4.1 Generation of SNX27 deficient mice 
4.1.1 Construction of a targeting vector and genotype analysis  
To define the physiological function of SNX27, a knockout mouse line was generated. 
The third exon encoding amino acids “179-243” forms the second part of the PX 
domain that is crucial for SNX27 function. Disruption of the exon “179-243” by 
insertion of a Neo-cassette would prevent synthesis of a functional SNX27 protein. A 
SalI endonuclease recognition site was introduced into the exon “179-243” by site-
directed mutagenesis and a targeting vector was constructed by inserting the Neo-
cassette into this side. An 8 kb right arm and a 4 kb left arm flanking the insertion 
were cloned into the pBluescript  SK+ vector (Stratagene) (Fig. 4.1, A and B). The 
targeting vector pBluescript SK+ was linarized and the targeting construct was 
transfected into embryonic stem cells (E-14) via electroporation. Selection of 
transfected cells was done using Gentamycin 418. Primers, RT-01(5’ TGA GTG CTG 
GGA TTA AAG GCA TGC) and RT-neo (5’CCA TCT TGT TCA ATG GCC GAT 
CC), were used for genotyping ES cell DNA extractions to identify the correct 
recombination between the genome and the targeting construct (Fig. 4.1C), and the 
correct targeted ES cells were used for blastocyst microinjection. 
4.1.2 Obtaining of SNX27-/- mutants 
4 male mice with 50-60% of chimerism were obtained after injection. Chimeras were 
used for crossing with Sv129Ole females to obtain F1 generation. To check for their 
genotype, a new PCR strategy was developed for extracted mouse tail DNA. Primers:  




CCA GGT ATA C) and KO-neo (5’GGC CGC TTT TCT GGA TTC ATC G) were 






Fig. 4.1: Schematic drawing of SNX27 genomic fragment, targeting vector 
and the screening for positive ES clones. (A), Mouse SNX27 genomic 
organization. (B), Targeting construct. (C), A 2000bp band was detected by PCR 
from the correctly targeted ES cell colony. 
Fig. 4.2: SNX27 protein is undetectable in SNX27-/- mice. (A), PCR analysis 
of genomic DNA isolated from mouse tails. (B), Western blot analysis of 
tissue lysates derived from the indicated mice using the rabbit anti-SNX27 
antibodies. 











Fig. 4.3: Birth defects of SNX27-/- mice. (A), The ratio of newborn SNX27-/- mice 
is only 16%, lower than the expected 25%, indicating the loss of some of SNX27-/- 
mice during early development. Among 152 newborn pups, 25 were -/-, 44 were 
+/+ and 83 were +/-. (B), Newborn SNX27-/- mice were smaller in size compared 
with wild-types in the same litter. (C), Newborn body weight comparison among 
+/+, +/- and -/- mice showed that SNX27-/- mice were significantly lighter. n=10. 















   
























Fig. 4.4: SNX27 deficiency results in postnatal growth retardation and 
postnatal lethality. (A), Picture shows the growth retardation of SNX27-/- mouse. 
Wild-type (+/+; Left) and SNX27-/- (-/-; Right) mice were from the same litter at 10 
days after birth. The SNX27-/- mouse grew markedly smaller. (B), Growth curves of 
SNX27-/- mice and wild-type mice over time. All SNX27-/- mice died before 
weaning, whereas all wild-types survived. n=10. (C), Images of organs dissected 





Respectively, a 300 bp fragment which was derived from the neo-gene by primers: 
KO-02 and KO-neo was used to identify heterozygous and homozygous mice. 
Crosses between F1 heterozygous mice gave rise to homozygotes. Lysates from 
various tissues such as the brain and kidney were probed with the rabbit polyclonal 
anti-SNX27 antibodies and showed that SNX27-/- mice did not express either SNX27a 
or SNX27b, while the heterozygous mice expressed about half of the amount of 
SNX27 as the wild-type did (Fig. 4.2). The reduced levels of SNX27 protein in 
heterozygous mice is because of the gene-dose effect. All the data above indicate that 
this line of mice is a complete null for SNX27.  
 4.2 Analysis of SNX27 deficient mice 
4.2.1 Birth defects of SNX27-/- mice 
Genotype check of more than 150 newborn pups revealed that the percentage of 
homozygous mice born was 16% instead of the expected 25%, suggesting that some 
homozygotes died in the uterus (Fig. 4.3A). Indeed, we detected some under-
developed homozygous embryos reabsorbed during gestation. The body weights of 
newborn SNX27+/+ and SNX27+/- mice were about 1.29 g, compared with 1.03 g for 
SNX27-/- mice (Fig. 4.3B). These findings suggest that SNX27 plays an important, 
although not absolutely necessary, role in early mouse development, growth and 
survival. 
4.2.2 SNX27 deficiency results in postnatal growth retardation and lethality  
Although most SNX27-/- mice were viable at the birth, they failed to thrive and all 
died within 3 weeks (this period corresponds to changing from mother-milk to self-




21), while the heterozygotes behaved just like the wild-type (lived up to 24 months). 
A tendency for delayed weight gain in SNX27-/- mice was seen at the first week. After 
the first week, the SNX27-/- pups showed significant growth retardation compared 
with their wild-type siblings. Fig. 4.4A shows the general appearances of SNX27-/- 
and SNX27+/+ mice at PN10 (postnatal day 10). The growth curves of SNX27+/+ and 
SNX27-/- pups during the suckling period are shown in Fig. 4.4B (pups are from 
different breeding cages). The growth retardation is not only reflected in the body 
weight but also in multiple organs. The sizes of multiple organs such as the brain, 
kidney, liver, heart and intestine were significantly reduced in the SNX27-/- mice (Fig. 
4.4C). These results suggest that SNX27 plays an essential role in postnatal growth 
and viability. 
4.2.3 SNX27-/- mice displayed striking abnormalities in the kidney development  
Anatomical examination is an important tool to investigate organ defects. Since 
SNX27 depletion caused mice growth retardation and postnatal death, this analysis 
was carried out on the SNX27-/- mice in Sv129Ole/C57BL mixed background.  
Initially, we performed histological examination of the major organs from newborn 
pups at PN1 to study the role of SNX27 in embryonic development. No gross 
abnormalities were observed in the liver, kidney or lung, even though SNX27 is 
highly expressed in all these mouse organs (data not shown).  
Then, we next changed to a later time point to further explore the role of SNX27 in 
postnatal organ development. We chose PN14 as the time point, because at this point 
all the mouse organs are nearly completely developed and most of the SNX27-/- pups 




and dissected. The brain, lung, liver, spleen, kidney, intestine and pancreas were fixed 
in 4% PFA and processed for histology analysis.  
The kidneys of SNX27-/- mice exhibited significant developmental abnormalities. The 
effect of SNX27 deficiency on kidney growth was shown in Fig. 4.5. Light 
microscopy examination showed a fully developed kidney in the wild-type pup which 
had well developed tubules in the cortex and medulla. The interstitial area between 
the cortex and medulla was free of fibrosis. However, abundant interstitial materials 
were observed in the inner cortex-outer medulla junction in the SNX27-/- pup kidney. 
This region is the main cell proliferation sites of both the descending and ascending 
limbs of the loops of Henle in the developing kidney (Cha et al., 2001). Studies from 
many research groups (Neiss, 1982; Kim et al., 1996) have demonstrated that the 
immature thick ascending limb epithelium cells transformed into the ascending thin 
limb during the first 2 weeks after birth. At PN14, the loops of Henle have finished 
transformation and elongation (Kim et al., 1996). The abundant interstitial materials 
between the cortex and medulla in the SNX27-/- mice indicated the nephron 
development and maturation were affected. 
In contrast, no obvious anatomical abnormalities were found in the lung, liver, spleen, 
pancreas and intestine (Fig. 4.6).  
These findings suggest that SNX27 plays an important role in postnatal mouse kidney 
development. Moreover, the final concentration of the urine depends on the medullar 
osmotic gradient which is built up by the loops of Henle. And the normal renal 
architecture is crucial for maintaining the water and electrolyte homeostasis (Burkitt 
et al., 1993). Hence, the abnormal nephron structures in the SNX27-/- mice also 






Fig. 4.5: The kidneys of PN14 SNX27-/- mice exhibited significant 
developmental abnormalities. The growth of the collecting system and the 
differentiation of tubular structure were affected in PN14 SNX27-/- mice. 
Representative sections of the kidney from wild-type (+/+; left) showed well-
developed tubular structure and absence of fibrosis. In contrast, the sections 
from SNX27-/- kidney (Right) showed abundant interstitial materials at inner 
cortex-outer medulla junction (arrowheads). Magnification: upper, 50X. 
lower, 200X. 
50X








Fig. 4.6: Histological analysis of major tissues from 14-day-old wild-type and 
SNX27-/- mice. No gross morphological defects were found in the pancreas (a 
and a’), lung (b and b’), intestine (c and c’), liver (d and d’) and spleen (e and e’) 
in SNX27-/- mice (-/-) compared with wild-types (+/+). Bars: 100µm. 























4.2.4 Kidney morphological study in SNX27-/- mice revealed delayed nephron 
maturation and papillary atrophy  
Based on the histological analysis, we proposed that SNX27 would function in renal 
development and morphogenesis, as well as tissue homeostasis. To evaluate the 
function of SNX27 in the kidney development, we analyzed the SNX27-/- mice renal 
morphology at various postnatal stages. The kidneys of SNX27-/- mice and their wild-
type siblings at embryo day 14.5 (E14.5), PN1 (postnatal day 1), PN7, PN14 and 
PN20 were harvested and processed for histological study. No obvious renal 
development defects were observed at E14.5 or PN1. As shown in Fig. 4.7, at E14.5, 
normal S-shaped nephron bodies were formed in SNX27-/- mice and the numbers 
were comparable with the wild-type kidney. At PN1, the S-shaped nephron bodies 
developed into short nephrons in both SNX27-/- and wild-type pups. This result 
indicated SNX27 is not essential at early stages of metanephrogenesis. The obvious 
renal developmental defects of the SNX27-/- pups could be detected at PN7. Fig. 4.8 
showed the elongated nephron tubules projected into inner medulla in the wild-type 
pups, but in the SNX27-/- kidneys, this area was absent of nephron tubules. 
At PN 14, the kidney maturation was significantly delayed in SNX27-/- pups. Fig. 4.9 
showed the cross sections of the SNX27-/- and wild-type mice kidneys. In the wild-
type kidney, the short loops of Henle have accomplished elongation to achieve the 
adult conformation. In contrast, abundant interstitial materials and poor tubule 
differentiation were still present in the nephrogenic zone of the SNX27-/- kidney. The 
SNX27-/- kidney also displayed a significant atrophic papilla and a considerable larger 
pelvis. The immature nephrogenesis could potentially reduce the urine concentration 
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Fig. 4.7: H&E staining of E14.5 and PN1 mouse kidney sections. (A), 
No gross anatomical abnormality was found at E14.5. The S-shaped 
bodies (indicated by arrowheads) formed normally in SNX27-/- mice (-/-; 
a’ and b’) and in numbers comparable with wild-types (+/+; a and b). 
Magnification: a and a’, 50X. b and b’, 200X. (B), At PN1, the S-shaped 
bodies transformed into short nephrons in both SNX27-/- (c’ and d’) and 











Fig. 4.8: H&E staining of PN7 mouse kidney sections. Sections of 
kidneys from wild-type (+/+; a and b) and SNX27-/-(-/-; a’ and b’) mice 
at 7 days of age. Elongated nephron tubules projected into inner medulla 
in the wild-type kidney (b, arrowheads). But in the SNX27-/- kidney, this 
area was absent of elongated tubules. Magnification: a and a’, 50X. b 









Fig. 4.9: H&E staining of PN14 mouse kidney sections. Cross sections of the 
kidneys from wild-type (+/+; a, b and c) and SNX27-/- (-/-; a’, b’ and c’) mice at 14 
days of age. The SNX27-/- kidney (a’) showed atrophic papilla (arrowhead). b and b’ 
indicated the kidney medullar area. In the SNX27-/- kidney (b’), abundant interstitial 
materials were detected (arrowheads), comparing to the normal developed wild-type 
kidney. c and c’ indicated the collecting ducts in the renal papilla. In the SNX27-/- 
kidney (c’), abnormal dilated collecting ducts (arrowheads) were detected. 
Magnification: a and a’, 25 X. b, b’, c and c’, 630X. 
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Fig. 4.10: H&E staining of PN20 mouse kidney sections. Cross sections of the 
kidneys from wild-type (+/+; a and b) and SNX27-/- (-/-; a’ and b’) mice at 20 days of 
age. Pelvic dilatation was present in SNX27-/- mice with atrophic papilla compared to 
wild-type mice. Numerous condensed nuclei can be detected in SNX27-/- medullar 




Fig. 4.11: Enhanced apoptosis at PN20 in SNX27-/- kidneys. Apoptosis in wild-
type (+/+; A, B, E, and F) and SNX27-/-(-/-; C, D, G and H) kidney medulla at 
PN14 (A to D) or PN20 (E to H) was visualized by fluorescence microscopy using 
the TUNEL assay (green; A, C, E and G). Nuclei are stained in blue (B, D, F and 
H). Specific TUNEL stained nuclei were shown on G and H. Magnification: 400X. 
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Lastly, at PN20, the medullar area was filled with collecting tubules which indicated 
the nephrogenisis was completely achieved in the SNX27-/- kidney, but massive 
condensed nuclei could be found in the medulla and a significant atrophic papilla was 
found (Fig. 4.10). 
We next examined if apoptotic alterations contributed to the renal pathogenesis. Little 
apoptotic activity was observed by TUNEL assay in the wild-type medullar 
cryosections (Fig. 4.11, A and E). However, extensive apoptosis was observed in this 
area in PN20 SNX27-/- mice (Fig. 4.11G).  
Taken together, these results suggest that the development of the loops of Henle in the 
SNX27 knockout mice was delayed for about a week compared with the wild-type. 
Furthermore, induction of accelerated apoptosis was observed in the third postnatal 
week with significant tubular degeneration in SNX27-/- kidney.  
4.3 Reducing milk competition can rescue some SNX27-/- pups 
In addition, we conducted a series of blood chemistry tests for the SNX27-/- pups. At 
PN14 the average blood glucose level of SNX27-/- mice is about 4.1 mM which is 
much lower than the averaged 8.4 mM for the wild-type controls (Fig. 4.12A). This 
result suggests that SNX27-/- pups suffered from insufficient nutrition uptake and they 
may be weaker in the competition for milk with their healthy siblings. In order to 
reduce milk competition, all SNX27+/- pups were removed at the PN3. Surprisingly, 
about 15% of the SNX27-/- pups survived to weaning (22/167).  However, most of the 
rescued SNX27-/- mice died at about 4-6 weeks of age and still displayed severe 
growth retardation (Fig. 4.12B). By far, only 3 male knockout mice lived to adulthood 




insufficient and many of the SNX27-/- pups died due to the milk competition, which 
can be partially relieved by removing the stronger pups. 
4.4 The kidneys of surviving SNX27-/- mice displayed progressive medulla 
degeneration 
We next analyzed the kidney morphology in a few survived SNX27-/- mice. Kidneys 
from one-month-old mice showed evidences of medulla atrophy with an enlarged 
renal pelvis space. Histological examination showed dilated collecting tubules in the 
medulla and some degenerated tissues in the medullar area (Fig. 4.13, A and B). 
The nephron tubules degeneration and impaired water balance in the kidney may 
result in kidney diseases such as hydronephrosis (Takahashi et al., 2000). The 3 male 
mice that survived to adulthood developed severe renal degeneration (Fig. 4.13C). 
Histological analysis revealed dilation of collecting ducts in the papilla in adult 
SNX27-/- mice (Fig. 4.13D). Taken together, these histological findings suggest that 
SNX27-/- mice may suffer from renal defects, and SNX27 is important for maintaining 










Fig. 4.12: The blood glucose level and image of rescued SNX27-/- mouse. (A), The 
blood glucose level of SNX27-/- pups was significantly lower. n=5. The means ± SD 
are shown. (B). One-month-old rescued SNX27-/- pups (by reducing milk competition) 
still showed growth retardation. Picture shows a wild-type mouse (+/+; upper) and a 
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Fig. 4.13: Rescued SNX27-/- mice kidneys displayed progressive medullar 
degeneration. (A), Kidney sections from wild-type (+/+) and SNX27-/-(-/-) mice at 
30 days of age were stained with H&E. The SNX27-/- kidneys displayed 
degenerated medulla and enlarged pelvis (arrowheads). Bar: 1 mm. (B), H&E 
stained sections showed dilated collecting tubules and interstitial materials in the 
medullar area of SNX27-/- kidneys (arrowheads). Magnification: 200X. (Fig. 













4.5 Urine chemistry analysis of one-month-old SNX27-/- mice 
24–hour urine collections of four SNX27-/- females and four wild-type females were 
obtained, and daily water intake was quantified after overnight equilibration in 
metabolic cages. SNX27-/- mice drank only about 60% volume of water and produced 
about 20% volume of urine compared with wild-types (Table 3). This result indicates 
SNX27 deficiency may cause significant alterations in drinking behaviours and urine 
output under non-stressed conditions. 
Significant physiological abnormalities were also found on random urinalysis and the 
data were shown in Table 3. The urine osmolality in the surviving SNX27-/- female 
mice was 1.5 fold higher than the wild-type. This data suggests the water reabsorption 
in the SNX27-/- mice nephron was increased. Beyond this, many urinary ion excretion 
Continued-Fig. 4.13: Rescued SNX27-/- mice kidneys displayed progressive 
medullar degeneration. (C), Overview of 10-month-old mice kidneys that had been 
fixed with PFA and crossly cut through the middle. Severe degenerated medulla in 
SNX27-/- kidney was observed. Bar:  1 cm. (D), H&E stained sections of kidney 
papilla showed dilation of collecting ducts in 10-month-old SNX27-/- mice 








concentrations were found higher in knockout mice. The comparisons are shown at 
Fig. 4.14. 
The most striking physiological abnormality in the SNX27-/- mice is the highly 
increased proteinuria in comparison with wild-type mice. The survived SNX27-/- mice 
excreted a small molecular weight protein of 20 kDa in their urine, which is five times 
more than controls (Fig. 4.15). The molecular size of this protein suggests that it is the 
mouse major urinary protein (MUP) (Szoka et al., 1980). MUP is produced mainly in 
the liver (Seyberth et al., 1985) and is excreted in the urine where it relates to sexual 
communication. The rat MUP homologue, α2u-globulin, is a marker for low 
molecular weight proteins absorption in the proximal tubules (Seyberth et al., 1985). 
This data suggests that the SNX27-/- mice may have an impaired ability in protein 
reabsorption in the proximal tubules, resulting in clinically detectable proteinuria and 
alterations in urinary concentrating capability. Alternatively, increased reabsorption of 
water could also potentially lead to reduced amount of urine and the increased levels 
of ions and proteins in the urine. 
 
 +/+, Wild-type mice; -/-, SNX27-/- mice. Data are means ± SD. n=4. 









Fig. 4.15: Analysis of urine proteins from one-month-old mice. Coomassie blue 
stained SDS-PAGE gel showed the excreted major urinal protein (MUP). 5µl 
mixed urine from the wild-type (+/+) and SNX27-/- (-/-) group. Each group contains 
four mice. 
Fig. 4.14: Comparison of urinalysis data from one-month-old mice.  




4.6 SNX27 may functionally regulate surface AQP2 levels 
Due to the abnormal water balance in SNX27-/- mice, we next tested whether renal 
water channels were correctly targeted in SNX27-/- kidneys. Aquaporins (AQPs) are 
major water channels that have been shown to play a critical role in rapid 
transportation of water through the plasma membrane (Nielsen et al., 2002; Nielsen et 
al., 2007). AQP2 is a well studied predominant vasopressin-regulated water channel 
in the kidney and plays a critical role in maintaining body fluid homeostasis. AQP2 is 
abundantly expressed in kidney collecting duct principal cells (Sasaki et al., 2000; 
Nielsen et al., 2002; Brown, 2003). Normally, AQP2 is stored in storage vesicles. 
Upon stimulation with vasopressin and activation of the receptor, intracellular 
signalling cascade causes fusion of the storage vesicles with the apical plasma 
membrane of the collecting duct cells. The regulated surface deployment of AQP2 via 
regulated fusion of vesicles enables physiological regulation of water reabsorption. 
Surface AQP2 can be recycled by endocytosis, a pathway that is independent of 
hormonal stimulation (Gustafson et al., 2000; Sun et al., 2002). Sun et al. showed 
direct evidence that AQP2 is internalized by a clathrin-mediated mechanism (Sun et 
al., 2002). We have examined the level and distribution of AQP2 in the kidneys of 
control and SNX27-/- mice. Interestingly, the level of AQP2 was significantly 
increased in the apical region of SNX27-/- kidney collecting ducts (Fig. 4.16A), which 
could be due to increased amount of surface AQP2 and/or accumulation of AQP2-
containing vesicles at the apical region of SNX27-/- collecting duct cells. Increased 
expression of AQP2 and its enhanced surface distribution are known to cause water 
retention in conditions such as pregnancy and congestive heart failure (Nielsen et al., 
2002). One possible explanation is that upregulation of AQP2 in the SNX27-/- kidney 




higher urine osimolality of SNX27-/- mice, which may be part of the reasons for 
increased ion concentrations and protein levels. What triggers the increased 
expression of AQP2 is currently unknown, although it could be due to poorer capacity 
of the skin to prevent water evaporation so that the feedback mechanism is to absorb 
water more efficiently at the kidney. Another remaining issue is whether increased 
AQP2 is due to increased transcription and/or due to alterations of AQP2 trafficking 
and turnover.  
AQP2 is expressed in principal cells of the kidney collecting ducts (Sasaki et al., 2000; 
Nielsen et al., 2002; Brown, 2003). In the SNX27-/- mice, upregulation of AQP2 is 
associated with increased water absorption as evidenced by the increased urine 
osmolality, suggesting that the surface AQP2 is increased. Since surface AQP2 is 
regulated by the recycling pathway (Lu et al., 2004), one possible explanation is that 
SNX27 may be somehow involved in endocytosis and/or endosomal degradation of 
AQP2. In the absence of SNX27, endocytosis and/or degradation of AQP2 are 
compromised, leading to increased surface and total AQP2 levels. 
To explore whether SNX27 may regulate AQP2 trafficking, we have examined the 
sub-cellular localization of SNX27 in kidney collecting duct cells. 
Immunofluorescence microscopy of kidney cryosections showed that a significant 
fraction of SNX27 was co-localized with AQP2 at the apical region of collection duct 
cells (Fig. 4.16B). Consistently, double staining of SNX27 and AQP2 in freshly-
isolated collecting duct cells also revealed they were co-localizing in intracellular 
vesicles marked by AQP2 (Fig. 4.16C). The increased expression of AQP2 could be 
seen in SNX27-/- cells. These vesicles might be AQP2 storage vesicles. These results 




might be affected in SNX27-/- mice. Thus SNX27 may potentially regulate 
endocytosis and/or endosomal sorting of AQP2. 
4.7 Other phenotypes 
4.7.1 Male SNX27 -/- mice are infertile  
So far, 3 male SNX27-/- mice grew to adulthood but breeding pairs with either 
SNX27+/- or wild-type female mice were unsuccessful. No off-springs were available 
during their entire lives. To evaluate a possible infertility of the male SNX27-/- mice, 
testicular morphology was analyzed. Histological evaluation demonstrated profound 
germ cell degeneration in the testis of adult SNX27-/- mice (Fig. 4.17A, arrowheads) 
compared with wild-type mice.  
4.7.2 Some SNX27-/- mice showed severe brain atrophy  
Anatomical analysis of SNX27-/- mice also revealed atrophic brains in a small fraction 
of knockout mice. Those knockout mice with brain atrophy had abnormal 
accumulation of cerebrospinal fluid (CSF) in the ventricles of their brains. 
Histological study showed their brains were poorly developed with much thinner 
cortex compared with the normal ones (Fig. 4.17B). In human patients, brain atrophy 
may cause mental disability and disease (Pearlson et al., 1990). This result also 
suggests the balance between production and absorption of CSF in SNX27-/- mice is 
somehow affected in some mice.  
Collectively, SNX27 may play an important role in the postnatal development of a 







Fig. 4.16: Increased AQP2 expression in SNX27-/- kidneys. (A), Kidney 
cryosections from wild-type (+/+) and SNX27-/- (-/-) mice were stained for AQP2 
(green). Images showed upregulated AQP2 expression in SNX27-/- collecting ducts. 
Nuclei are stained in blue by DAPI. Magnification: 400X. (B), Wild-type kidney 
cryosections stained for AQP2 (green) and SNX27 (red). Images showed co-
localization of both proteins in collecting duct principal cells (arrowhead indicates 
the overlapping). Magnification: 400X. (C), Primary collecting duct cells were 
isolated from wild-type (+/+) and SNX27-/- (-/-) kidneys and cultured in vitro for three 
days and then subjected to immunofluorescence microscopy to reveal the staining for 
AQP2 (green) and SNX27 (red). Images showed co-localization of both proteins in 
wild-type cells and the upregulated expression of AQP2 in SNX27-/- cells which lack 

























Fig. 4.17: Histological comparison of testis and brains from wild-type 
and SNX27-/- mice. (A), Cross section from an adult SNX27-/- mouse testis 
showed germ cells in the seminiferous tubule exhibiting darkly stained 
condensed nuclei (arrowheads). Magnification: upper, 100X. lower, 630X. 
(B), Cross section from a PN20 SNX27-/- mouse brain showed that the brain 
atrophy resulted in thinner cortex (arrowhead). Magnification: 25X. 





Fig. 4.18: Protein expression levels of Kir3 channel in the brains of newborn 
SNX27-/- and wild-type pups. (A), Western blot analysis of brain lysates from wild-
type (+/+) and SNX27-/- (-/-) mice showed no expression of SNX27 in knockout mice 
and the levels of Kir3.1, Kir3.2c and Kir3.3. (B), Results from four independent 
experiments exampled in A were quantitated by densitometric analysis. Quantitative 
data of Kir3 channel expression in mouse brains were normalized to the levels of β-





4.7.3 Altered expression of Kir3 channels in SNX27-/- mice  
Lunn et al. showed that SNX27 might be associated with G protein–gated potassium 
(Kir3) channels in the brain (Lunn et al., 2007). Functional study showed SNX27 
promoted the endosomal movement of Kir3 channels for lysosomal degradation. 
Overexpression of SNX27 led to reduced Kir3 surface expression. We next examined 
the Kir3 channel expression in the SNX27-/- mice brain. Newborn SNX27-/- and wild-
type pups from same litter were sacrificed and the brains were pooled and 




homogenized in RIPA buffer in the presence of complete EDTA-free protease 
inhibitor mixture. The lysates were centrifuged at 16,000Xg for 30 min at 4oC and the 
supernatant was collected, equal amounts of total proteins were analyzed by Western 
blot (Fig. 4.18A). The result indicated the expression of Kir3.2c was increased about 
40% but Kir3.3 was decreased for 10-20% in SNX27-/- mice brains (Fig. 4.18B). 
These results suggest that depletion of SNX27 altered Kir3 protein levels in the brain. 
One possibility is that the depletion of SNX27 resulted in arrest of 
endosomal/lysosomal sorting of Kir3 channels, which may thus facilitate Kir3.2c 
recycle rate and yet promote Kir3.3 lysosomal degradation. Consistent with the results 
from Slesinger’s laboratory, SNX27 could medicate Kir3 channel trafficking in the 
endosomal pathway of the neuron (Lunn et al., 2007). Future studies are required to 
sort out the underlying mechanism responsible for SNX27 to regulate the endosomal 
trafficking of these channels. 
4.8 Discussion 
After characterizing the biochemical and cell biological properties of SNX27, my 
study was then aimed to define the in vivo function of SNX27. We have generated the 
SNX27-/- mice through homologous recombination. SNX27a and SNX27b shared the 
same promoter but expressed differently during RNA splicing. The knock out 
construct would interrupter the protein expression for both isoforms and validated by 
using the anti- SNX27 antibodies. Our results suggest that SNX27a or SNX27b 
isoforms are not expressed in this  knockout mouse line. The present work 
demonstrates that SNX27 plays an essential role in postnatal growth of mice. Male 
and female SNX27+/- mice were viable, grew normally to adulthood, and appeared 
healthy without excess mortality for up to 2 years of observation. Organogenesis was 




SNX27. However, none of more than 100 SNX27-/- pups survived to weaning under 
normal conditions. Postnatal growth of the SNX27-/- mice was severely retarded. 
SNX27-/- pups displayed much reduced body weight, reduced sizes of multiple organs 
and delayed nephrogenesis of the kidney. 
Given the widespread importance of SNXs in membrane transport and the facts that 
SNX1-/-/SNX2-/- and SNX13-/- mice exhibit early embryonic lethality (Schwarz et al., 
2002; Zheng et al., 2006), I was surprised to find SNX27-/- pups were born after 
crossing heterozygous mice. Analyzing SNX27-/- mice allowed me to conclude that 
SNX27 plays an important role in postnatal growth of mice as the SNX27-/- mice 
exhibited severe postnatal growth retardation with reduced sizes of multiple organs. 
Histological examination of multiple organs revealed that the kidney displayed the 
most obvious alteration during postnatal development. As such, I have focused on the 
kidney development of SNX27-/- mice in comparison with control littermates. The 
initial pathologic abnormalities were seen in the PN14 SNX27-/- mice which showed 
significantly delayed nephrogenesis, but the organogenesis of the liver, lung, pancreas, 
spleen and intestine was relatively less affected without gross abnormality other than 
reduced sizes. 
The period of nephrogenesis is significantly different among different mammalian 
species. In some species such as human and sheep (Moritz and Wintour, 1999; Guron 
and Friberg, 2000), nephrogenesis is completed within an intrauterine environment. 
While some others such as the house mouse and the rat, nephrogenesis processes 
continue into the postnatal period. The house mouse undergoes nephrogenesis from 
E11 to PN5–7, with only 20% of its nephrons present at birth and then reaching the 
full endowment of about 11,000 nephrons (Lelievre-Pegorier et al., 1998; Guron and 




The mammalian kidney is composed of two embryologically distinct tissues: the 
nephrons which are derived from the metanephric blastema, and the collecting duct 
system which is derived from the ureteric bud (Evan and Larsson, 1992; Clapp and 
Abrahamson, 1994; Spitzer, 2003). Anatomically, the nephron is a “U” shaped 
structure, including the glomerulus, the proximal and distal convoluted tubules and 
the loops of Henle. The mature kidney contains two types of nephrons, superficial 
nephrons with short loops of Henle and juxtamedullary nephrons with long loops of 
Henle. The loops of Henle can be divided into four parts, including the thick 
descending limb, the descending thin limb, the ascending thin limb and the thick 
ascending limb. The transition zone from the ascending thin limb to the thick 
ascending limb defines the boundary between the outer and inner medulla (Burkitt et 
al., 1993; Kiuchi-Saishin et al., 2002; Chabardes-Garonne et al., 2003). 
In the developing rat kidney, before and at the time of birth, thick ascending limbs are 
present throughout the renal medulla extending from the tip of the papilla to the renal 
cortex. Thus all loops of Henle have the structural configuration of the short-looped 
nephrons (Tisher and Madsen, 1996). However, during the first 2 weeks of life after 
birth, the cuboidal epithelium of the thick ascending limb is gradually transformed 
into the ascending thin limb and the short loop of Henle undergoes considerable 
elongation to achieve the adult conformation (Kim et al., 1996; Cha et al., 2001). The 
main sites of cell proliferation in both the descending and ascending limb of the loops 
of Henle were found in the medullary rays, the inner cortex and the outer stripe of the 
outer medulla (Kim et al., 1996; Cha et al., 2001). 
The observed delay in nephrogenesis in SNX27-/- mice could potentially be explained 
by the defective transformation and elongation of the loops of Henle in the postnatal 




of loops of the Henle, excessive interstitial materials were instead found in the kidney 
of PN14 SNX27-/- mice with fewer cells exhibiting the morphology of loops of the 
Henle. The impaired kidney nephron structure would eventually delay their ability to 
set up a renal osmotic gradient. The immaturity of the neonatal kidney may contribute 
to medulla degeneration during growth. These results indicated that although SNX27 
is not so crucial for embryonic development, it is important for postnatal growth and 
development. In the kidney, postnatal development is important for the nephrogenesis 
and maturation of the loops of the Henle. SNX27-/- mice exhibited delayed 
nephrogenesis with accumulation of interstitial materials taking over the region that is 
normally occupied by maturing nephron tubules. The delayed nephrogenesis may 
result in an impaired kidney function and water balance in postnatal mice. 
The basis for postnatal death of SNX27-/- mice is not fully revealed. Among the 
various possibilities are the renal insufficiency and/or insufficient nutrition uptake. 
The insufficiency in nutrition uptake indeed contributed partially to the death as 
reducing milk competition during the sucking period by removing heterozygous 
littermates helped SNX27-/- pups to grow and survive as about 15% of the 
homozygotes can be rescued to grow beyond the weaning period. This allowed us to 
examine the kidney at later time points. At one month of age, the surviving SNX27-/- 
mice showed growth retardation and displayed the urine chemistry characteristic of 
increased osmolality. However, the majority of SNX27-/- mice rescued by reducing 
milk competition died during the 4-6 week period, suggesting that defective kidney 
function and/or other unknown alterations may contribute to the postnatal death of 
SNX27-/- mice. 
The increased osmolality of SNX27-/- urine suggests that the urine is over 




water absorption in the kidney collecting duct cells. The AQP2 is the major 
vasopressin-responsive water channel in the collecting duct cells. Examining the 
expression of AQP2 revealed that AQP2 levels were significantly enhanced, 
suggesting that increased AQP2 expression may enhance water absorption, which 
could be part of the mechanism that contributs to the increased urine osmolality of 
SNX27-/- mice. Furthermore, SNX27 was seen to co-localize with AQP2 in the 
collecting duct cells and increased levels of AQP2 is accumulated in the apical region 
of SNX27-/- collecting duct cells. Under physiological condition, AQP2 exists in a 
dynamic equilibrium between the plasma membrane and intracellular storage vesicles. 
Binding of vasopressin to the G-protein-coupled V2-receptor induces a series of 
coordinated signalling events in collecting duct cells that eventually leads to elevated 
levels of surface AQP2 and consequently increased water reabsorption (Nielsen et al., 
2002; Brown, 2003). AQP2 might be retrieved from the plasma membrane by 
endocytosis through a clathrin-mediated mechanism (Nielsen et al., 2002; Sun et al., 
2002; Brown, 2003). These endosomal AQP2 could be routed for degradation via the 
endosome-lysosome pathway or be re-secreted to the plasma membrane probably 
after endosomal sorting. Consequently, mutations in AQP2 result in autosomal 
nephrogenic diabetes insipidus and knockout of AQP2 gene in mouse results in 
diluted urine, polyuria and postnatal lethality, confirming the importance of this 
protein in urinary concentration (Rojek et al., 2006; Yang et al., 2006). We therefore 
hypothesize that absence of SNX27 may trigger upregulation of AQP2 either by 
transcriptional upregulation of AQP2 gene and/or increased stability and recycling of 





We also observed that SNX27-/- urine exhibited proteinuria with increased protein 
concentrations. Since the histological analysis showed no gross morphological defects 
in the glomerular basement membranes or endothelial cells, the proteinuria is unlikely 
to be caused by glomerular damage. It is more likely to be explained by either 
insufficient nephron reabsorbing ability and/or due to increased water absorption.  
Our results indicate that SNX27 may be involved in mouse embryogenesis because 
the SNX27-/- pups birth ratio is lower than the expected Mendelian ratio. The distinct 
phenotype may be due to the subtle genetic background of individual embryos. The E-
14 embryonic stem cells used in the present work have the genetic background 
Sv129Ole (Hooper et al., 1987). SNX27 heterozygous mice were obtained by 
crossing germ-line producing chimeras with C57BL mice. Afterwards, the mice were 
crossed among each other. Hence, SNX27 knockout mice have genetic information 
from both mouse strains, Sv129Ole and C57BL. To reduce the genetic heterogeneity 
of the SNX27-/- mice, I am crossing them back to Sv129Ole mice or to C57BL mice to 
get SNX27-/- mice with more pure genetic background. 
In summary, our results suggest that SNX27 plays an essential role in postnatal 
development and survival. Genetic inactivation of the SNX27 gene resulted in 
postnatal lethality, which can be partially prevented by reducing milk competition, 
suggesting insufficient nutrient uptake is part of the basis responsible for postnatal 
lethality. Furthermore, the postnatal development and maturation of kidney nephrons 
were severely affected with accumulation of interstitial materials occupying region 
that is normally populated with nephron tubules, although prenatal and early postnatal 
renal development were not dramatically altered. During 20 days of postnatal life, 
maturation of the juxtamedullary nephrons from inner cortex to outer medulla was 




and early nephron apoptosis. Over time, medulla degeneration and papillary atrophy 
were observed to progress. These renal histological changes are accompanied by renal 
diseases such as hyper-proteinuria and increased osmolality, which is partly due to 
increased expression of AQP2. Therefore, SNX27 is necessary for normal postnatal 
development and maturation of nephrons and for maintaining the normal water 
balance, although its roles in embryonic development and early renal differentiation 
are marginal. The exact mechanisms by which SNX27 modulates renal development 
and function need to be addressed in the future.  
In addition, SNX27-/- mice provide a good animal model for studying the role of 
SNX27 in the regulating of cell surface receptors and/or transporters, especially for 
those containing class I PDZ binding motif. From the study of Slesinger’s laboratory, 
SNX27 was suggested to regulate trafficking of Kir3 channels in the endocytic 
pathway (Lunn et al., 2007). Consistent with their results, the Kir3.3 protein 
expression is decreased but the kir3.2c level is increased in SNX27-/- mice. Since 
Kir3.2c and Kir3.3 both contain PDZ binding motif, the different effect of SNX27 
absence on their expression is unknown. One possibility is that PDZ domain of 
SNX27 binds the PDZ binding motif of Kir3.2c to promote endosomal sorting for 
lysosomal degradation. Absence of SNX27 will retard lysosomal targeting and 
promote recycling of Kir3.2c, leading to increased levels of Kir3.2c. The decreased 
levels of Kir3.3 could be due to the lysosomal targeting motif of Kir3.3 dominated the 
protein trafficking to lysosomes. Our data thus support the notion that SNX27 







CHAPTER 5: SNX27 REGULATES THE ENDOCYTOSIS OF EGFR 
5.1 ShRNA-mediated knockdown of SNX27 inhibited endocytosis of EGFR 
The prototype sorting nexin, SNX1, was initially identified for its ability to interact 
with a region of epidermal growth factor receptor (EGFR) that containing lysosomal 
targeting signals (Kurten et al., 1996). Overexpression of SNX1 was shown to 
enhance the lysosomal degradation of EGFR. Since this first discovery, the ability of 
a sorting nexin to affect the endocytosis of EGFR either by direct association (SNX1 
and SNX16) or through indirect machinery (SNX3 and SNX13) has provided a useful 
system to study sorting nexin functions (Kurten et al., 1996; Xu et al., 2001a; Zheng 
et al., 2001; Choi et al., 2004).  
Here, I have used RNA interference (RNAi)–mediated knockdown strategy to study 
the role of SNX27 in EGFR endocytosis pathway. Pools of A431 cells stably infected 
with the retrovirus-based vectors expressing shRNA targeting various regions of 
human SNX27 mRNA were assessed by immunoblot analysis. As shown in Fig. 5.1A, 
three shRNAs targeting different sites were tested for their efficiencies of suppressing 
the expression of SNX27 protein in cells. Two (shRNA878 and shRNA920) had no 
significant effect on SNX27 protein levels, whereas one (shRNA735) had the most 
efficient effect of suppressing SNX27 expression. We therefore used the pool of A431 
cells stably transduced with shRNA735 (KD-735) for subsequent analysis in 
comparison with cells transduced with a non-targeting scramble sequence shRNA 
(control shRNA), as cells transduced with control shRNA behaved like parental and 
vector-transduced cells in all analyses. The SNX27 expression levels in KD-735 cells 
and the control shRNA infected A431 cells are shown in Fig. 5.1B. The knockdown 
sequence is shared by both SNX27a and SNX27b. The immunobloting assay 













Fig. 5.1: Knockdown of SNX27 in A431 cells inhibited the endocytosis of 
EGFR. (A), A431 cells transduced with the vector: pSuper.Retro.puro (pSR, 
lane 1) and three shRNAs which target different sites of SNX27 mRNA (lanes 
2–4) were assessed by immunoblotting to detect SNX27 and β-actin. The 
shRNA735 had the most efficient effect in suppressing SNX27 expression (lane 
2). (B), A431 cells transduced with non-targeting scramble shRNA (control 
shRNA, Left) or shRNA735 (Right). The total cell lysates were subjected to 
SDS-PAGE and immunoblotting to detect SNX27 and β-actin. (C), Mixed KD-
735 and control cells as indicated were incubated with EGF-Rho (20 ng/ml) on 
ice for 60 min. After washing, the cells were incubated at 37 ºC for 0 hr (upper 
panels) or 3 hr (lower panels). Cells were analysed by indirect 
immunofluorescence microscopy to detect SNX27 (green) and EGF-Rho (red). 
Nuclei were stained by DAPI (blue). Bar: 10 µm.  





















       
Continued-Fig.5.1: Knockdown of SNX27 in A431 cells inhibited the 
endocytosis of EGFR. (D), A431 cells transduced with non-targeting shRNA 
(Control, Left) or shRNA735 (KD-735, Right) were surface-biotinylated with 
sulfo-NHS-SS-biotin. After incubation with EGF (100 ng/ml) at 37 ºC for the 
indicated period of time, surface-exposed biotin was removed by stripping in 
reducing buffer. Cell lysates were incubated with streptavidin-beads to recover 
biotinylated proteins that have been endocytosed, which were analysed by 
immunoblotting to detect EGFR. (E), Results from four independent 
experiments exampled in D were quantitated by densitometric analysis. Each 
signal is normalized against the level of β-actin detected at each time point. 
Values are expressed as ratio of signal at each time point to signal detected at 0 
















Next, we examined the effect of suppressing SNX27 on the trafficking of Rhodamine-
conjugated EGF (EGF-Rho). The shRNA735 transduced A431 cells (KD-735) were 
mixed with control shRNA infected A431 cells and incubated with EGF-Rho on ice 
for 60 min to allow the binding of EGF-Rho to EGFR on the cell surface. After 
extensive washing to remove excess/unbound EGF-Rho, cells were incubated at 37 ºC 
for 3 hr to allow the internalization and delivery of EGF-Rho to the lysosome for 
degradation. A set of cells was not incubated at 37 ºC to visualize the surface-bound 
EGF-Rho (0 hr). The effect of internalization and degradation of EGF-Rho is shown 
on Fig. 5.1C. Control cells and SNX27 knockdown cells all exhibited comparable 
levels of binding of EGF-Rho (Fig. 5.1C, upper panel), which has a characteristic 
surface appearance highlighted by the strong labeling of cell boundaries. At the 3hr 
time point (Fig. 5.1C, lower panel), decrease of EGF-Rho labeling was observed in 
cells expressing SNX27, probably due to the endocytosis and lysosomal degradation. 
However, in SNX27 knockdown cells, significant amount of EGF-Rho remained 
detectable on the plasma membrane and intracellular punctates. This observation 
suggests that depletion of SNX27 delayed the endocytosis and/or lysosomal targeting 
of EGF-Rho. 
To independently and more quantitatively measure the internalization of EGFR from 
the cell surface, we next examined the kinetics of the internalization of surface-
biotinylated EGFR in response to EGF stimulation (Fig. 5.1D), followed by 
quantitative analysis by densitometry (Fig. 5.1E).  
A431 cells transduced with shRNA715 (KD-735) or control shRNA (Control) were 
surface-biotinylated by the cleavable biotin to biotinylate all surface-exposed proteins 
such as the EGFR and TfR. After extensive washing, biotinylated EGFR was 




then quickly chilled on ice to stop additional endocytosis and were then treated with 
membrane-impermeable reducing reagents to remove the biotin which was attached to 
surface-exposed EGFR, a process referred to as surface stripping. The biotin attached 
on EGFR molecules that have already been internalized is resistant to this surface 
stripping. The biotinylated EGFR can be retrieved by straptavidine beads for detection 
by immunoblotting. In this way, the amount of biotinylated EGFR that is resistant to 
surface stripping serves as a quantitative measure for the amount of internalized 
EGFR. Using this approach, essentially all surface-biotinylated EGFR was sensitive 
to the surface stripping at the beginning of EGF stimulation (Fig. 5.1D, lane 2, left 
panel). Within 2 min of stimulation, about 40% of EGFR became resistant to surface 
stripping in control cells (Fig. 5.1D, lane 3, left panel), suggesting that 40% of EGFR 
had been sequestered into clathrin-coated vesicles that were no longer accessible to 
the externally applied reducing agents. The amount of internalized EGFR increased 
gradually over 5-15 min with more than 80% of biotinylated EGFR became resistant 
to surface stripping after 15 min of internalization (Fig. 5.1D, lane 4-5, left panel). On 
the other hand, in SNX27 knockdown cells (Fig. 5.1D, right panel), the majority 
(about 85%) of EGFR remained sensitive to surface stripping after 2 min of 
stimulation because only around 15% of EGFR was internalized. The amount of 
internalized EGFR increased gradually over 5-15 min period with about 40% of 
EGFR internalized after 15 min of stimulation (Fig. 5.1D, lane 4-5, right panel). The 
most dramatic reduction of internalization of EGFR was at the 2 min time point, from 
40% in control cells to 15% in SNX27 knockdown cells. This period is the early 
events of EGFR endocytosis, which is to sort and sequester EGFR into clathrin-coated 
vesicles. These results suggest that SNX27 is likely regulating the early events of 




5.2 Depletion of SNX27 inhibited lysosomal degradation of EGFR  
To independently study the role of SNX27 in receptor endocytosis, next we examined 
the consequence of knocking down SNX27 on EGFR degradation (Fig. 5.2). After 
stimulated with EGF (100 ng/ml) for 3 hr, about 60% of EGFR was degraded in A431 
cells transduced with control shRNA (Control). However, EGFR degradation was 
compromised in SNX27 knockdown cells (KD-735) with only 30% of EGFR being 
degraded. These results suggest that SNX27 plays an important role in the events of 
sorting/sequestering activated EGFR into clathrin-coated vesicles, as well as 






Fig. 5.2: Depletion of SNX27 inhibited the lysosomal degradation of EGFR. 
(A), Non-targeting shRNA (Control) and shRNA735 (KD-735) transduced A431 
cells were incubated with EGF (100 ng/ml) at 37 ºC for 0 or 3 hr. Cell lysates were 
analysed by immunoblot to detect EGFR at 0 hr and 3 hr, the level of β-actin 
serving as loading control. (B), Results from four independent experiments 
exampled in A were quantitated by densitometric analysis for EGFR levels at 0 and 
3 hr. After being normalized against the level of β-actin, the average of the 
percentage of EGFR detected at 3 hr was presented, comparing to the EGFR level at 
0 hr. Data shown are means ± SD. P<0.05. 
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Fig. 5.3: Direct visualization of EGF endocytosis by live cell imaging. (A), 
ShRNA735 (KD-735) and non-targeting shRNA (Control) transduced A431 cells 
were incubated with OG-EGF (20 ng/ml) on ice for 60 min. After extensive washing, 
the cells were incubated at 37 ºC for 60 min to allow EGF internalization. Surface and 
intracellular fluorescent vesicles were visualized on Olympus Fluoview inverted 
microscope. Images were acquired one frame/min. Selected photographs of every 15 
min are shown. (B), Figure shows the normalized vesicle numbers inside each cell 
during each minute (n>20 random picked cells). Bars: 10 μm.  
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5.3 Direct visualization of EGFR endocytosis using live cell imaging technique 
To directly address a role of SNX27 depletion on the effect of EGFR internalization, 
we have monitored the internalization of fluorescent labeled EGF by live cell imaging. 
Non-targeting  shRNA (Control) and shRNA735 (KD-735) transduced A431 cells 
were incubated with oregon green 488 labeled EGF (OG-EGF) on ice for 60 min to 
allow binding of OG-EGF to EGFR on the cell surface. After extensive washing to 
remove excess/unbound OG-EGF, cells were incubated at 37 ºC for 1 hr to allow the 
internalization and delivery of OG-EGF to the late endosome/lysosome. Surface and 
intracellular fluorescent vesicles were visualized on Olympus Fluoview inverted 
microscope. Images were acquired one frame/min, using 60X Apochromat objectives 
(Fig. 5.3A). The number of endocytosed vesicles inside each cell was analyzed using 
Cell-P-Software by Olympus (Fig. 5.3B). This data further demonstrates that the 
endocytosis of EGFR complex was markedly slowed down in the SNX27 knockdown 
cells. 
5.4 Discussion 
Members of sorting nexin family have been shown to regulate the endosomal 
transport of a variety of surface receptors such as the epidermal growth factor receptor 
(EGFR), the transferrin receptor (TfR) and the low-density lipoprotein receptor 
(LDLR) (Kurten et al., 1996; Xu et al., 2001a; Stockinger et al., 2002).  
In this chapter, we analyzed the effect of knocking down SNX27 in the EGFR 
endocytosis pathway. The EGFR is an example of a family of surface proteins, termed 
receptor tyrosine kinases (RTKs) (Schlessinger, 2004; Citri and Yarden, 2006). EGF 




complex. The receptor and EGF are then transported to lysosomes for degradation 
(Katzmann et al., 2002).  
Our results imply that the SNX27 is important for the endocytosis of EGFR. Firstly, 
degradation of internalized EGF-Rho was retarded at the level of the plasma 
membrane in SNX27 knockdown cells. One of the possible explanations is that, 
SNX27 may mediate the EGFR targeting to the early sorting endosome. Thus 
suppression of SNX27 resulted in the delayed segregation of EGF from the plasma 
membrane to the early endosome. Secondly, depletion of SNX27 inhibited EGF 
stimulated EGFR endocytosis and significantly delayed the degradation of EGFR. 
Lastly, we used the direct fluorescence microscopy to monitor the EGFR endocytic 
vesicles transporting from the plasma membrane into the sorting endosome, which 
was indeed slowed down in the SNX27 knockdown cells. Taken together, our results 
imply a function of SNX27 in the regulation of the endocytosis and endosomal 
trafficking of EGFR.  
However, we could not identify a direct interaction of SNX27 with the EGFR. One 
explanation is that, SNX27 interacts with PI(3)P and targets to the early endosome 
through the PX domain. Depletion of SNX27 may lead to physiological changes of 
the early endosomes, which interrupted the equilibrium of protein trafficking between 
the early, recycling and late endosomes. Furthermore, whether SNX27 would 
transiently associate with activated EGFR during the very early events of EGF 
stimulation remains to be studied. Importantly, it is necessary to introduce mouse 
SNX27 into the SNX27 knockdown pools to find out whether it is able to rescue the 
delayed endocytosis of EGFR. More extensive future characterization is needed to 
draw a firm conclusion, regarding the role of SNX27 in endocytosis and endocytic 




CHAPTER06:0IDENTIFICATION OF NMDA RECEPTOR-2C AS A SNX27-  
0000000000000INTERACTING PROTEIN 
 
6.1 Gal4 based yeast two-hybrid screening to identify candidate SNX27 
interacting proteins 
Identifying SNX27 interacting partners is one of the approaches to unveil its cellular 
functions and underlying mechanisms. Yeast two-hybrid screening is a widely used 
method to find potential interacting candidates. Thus, a Gal4 based yeast two-hybrid 
screening for proteins interacting with SNX27 were performed. We chose the longer 
isoform SNX27a full length (SNX27aFL) as the bait and transformed pGBKT7-
SNX27aFL into yeast cell Y187. After confirming that pGBKT7-SNX27aFL was 
normally expressed in the yeast cells (data not shown), SNX27aFL containing yeast 
cells (Y187) were mated with yeast AH109 pretransformed with human brain cDNA 
library (Clontech) and subsequently plated on the selective medium with the highest 
stringency (SD/-Leu/-Trp/-His/-Ade, Quadruple Drop Out medium, QDO). 
It was estimated that 2 x 106 cDNA clones were screened, 68 colonies appeared after 
2 weeks growth selection. After further selected on QDO- X-α-Gal plate, 30 positive 
colonies were finally picked up. The plasmids carried by these yeast cells were 
subsequently extracted and sequenced. The interaction candidates are listed in Table 4. 
Through yeast two-hybrid assay, we identified a novel SNX27 interacting partner, the 
N-methyl-D-aspartate (NMDA) receptor 2C (NR2c). NMDA receptors are ligand-
gated ion channels that have a high permeability for Ca2+ found in the central nervous 
system (Lau and Zukin, 2007). The NMDA receptor has been demonstrated to play an 
essential role in long-term potentiation (LTP). LTP is a widely considered cellular 
mechanism that is implicated with learning and memory (Malinow and Malenka, 




PDZ domain containing proteins such as synapse-associated protein-102 (SAP-102), 
and postsynaptic density protein of 95 kDa (PSD-95). The interaction stabilizes the 
number of surface NMDAR which represents a balance between receptor 
internalization and insertion (Kim and Sheng, 2004). We next verified the interaction 
between SNX27 and NR2c through yeast two-hybrid and immunoprecipitation assays. 
 






6.2 Direct PDZ domain mediated interaction of SNX27 with NR2c 
Based on the sequencing results from the yeast two-hybrid screening, the identified 
NR2c construct contains the coding region for the C-terminal region aa1066-1236 
(NR2c-CT). To define whether the PDZ domain of SNX27 is responsible for the 
interaction with NR2c, a series of SNX27 truncated mutations were made to further 
analyze the SNX27-NR2c interaction through yeast two-hybrid assays. SNX27aFL, 
SNX27NT, SNX27a∆PDZ, SNX27a∆PX, SNX27a∆RA and SNX27aCT 
encompassing different portions of the protein were subcloned into the pGBKT7 
vector and transformed into yeast Y187 (Fig. 6.1A), and the purified pGADT7-NR2c-
CT was re-transformed into yeast AH109. All constructs were analyzed for normal 
protein expression. Transformed AH109 and Y187 yeast cells were mated and the 
resulting diploid yeast cells were grown on SD medium lacking leucine and 
tryptophan (SD/-Leu/-Trp) for 2 days. Then the cells were plated on highly stringent 
SD medium lacking leucine, tryptophan, histidine and adenine (SD/-Leu/-Trp/-His/-
Ade; Fig. 6.1B). Those SNX27 constructs lacking the PDZ domain were unable to 
interact with NR2c-CT, whereas interaction was observed for the constructs encoding 
the complete protein or the PDZ domain (Fig. 6.1B). These results not only confirmed 
the interaction of SNX27 with NR2c but also strongly suggest a direct association 











Fig. 6.1: Characterization of the SNX27-NR2c interaction using the yeast two-hybrid 
assay. (A), Diagrammatic representation of the SNX27a deletion mutants. Six constructs were 
cloned into the pGBKT7 vector. (B), SNX27 constructs in pGBKT7 vector were transformed 
into yeast AH109. The purified NR2c-CT (aa 1066-1236) in pGADT7 was re-transformed into 
yeast Y187. Transformed AH109 and Y187 yeast cells were mated and plated on leucine and 
tryptophan-free SD plate (SD/-Leu/-Trp, left). To confirm interacting proteins, mated yeast 
cells were grown on highly stringent QDO plate (SD/-Leu/-Trp/-His/-Ade) (right). 
 










6.3 The PDZ binding motif is critical for the interaction of NR2c with SNX27 
It is noteworthy that the identified pGADT7-NR2c-CT construct contains a class I 
PDZ binding motif (PDZbm): “SEV” (Fig. 6.2A). This promoted us to analyze the 
requirement of the NR2c PDZbm in this interaction. We next performed co-
immunoprecipitation assay to provide direct biochemical evidence for a physical 
association of SNX27 with NR2c C-terminus. The rat NR2c-CT (aa 1066-1236) and 
NR2c-CTΔSEV (aa1066-1233) were subcloned to pDMyc from pBluescript-NR2cFL 
(Fig. 6.2B). HEK293T cells were co-transfected with Myc-tagged NR2c-CT (or Myc-
tagged NR2c-CTΔSEV) and one of the HA-tagged SNX27a isoforms (Fig. 6.2, B and 
C). Cell lysates were immunoprecipitated with anti-Myc cross-linked agarose beads. 
The immunoprecipitates were analyzed by immunoblotting with anti-Myc antibodies 
to determine the efficiency of the immunoprecipitation, as well as with anti-HA 
antibodies to detect the amount of co-immunoprecipitated HA-tagged SNX27.  
The result from the co-immunoprecipitation experiments revealed that the NR2c-CT 
interacted with SNX27aFL (Fig. 6.2C, lane 1). In contrast, SNX27aFL was not 
immunoprecipitated by the PDZbm-deleted form: NR2c-CTΔSEV (Fig. 6.2C, lane 4), 
supporting the notion that the PDZbm is important for interaction with SNX27. 
Furthermore, the SNX27NT (Fig. 6.2C, lane 3), but not the PDZ domain-deletion 
mutant (SNX27ΔPDZ, Fig. 6.2C, lane 2), was immunoprecipitated by the NR2c-CT.  
Collectively, our results suggest that the PDZ binding motif “SEV” is crucial for the 








Fig. 6.2: The PDZ binding motif is critical for the interaction of NR2c with 
SNX27. (A), Alignment of the C-terminal amino acid sequence of human, rat and 
mouse NR2c showed the conserved class I PDZ binding motif “SEV” (upper panel). 
The alignment of the C-terminal amino acid sequence of human NR2a, NR2b, NR2c 
and NR2d showed the conserved class I PDZ binding motif “SXV” (lower panel). (B), 
Diagrammatic representation of the SNX27a and NR2c deletion mutants. (Fig. 





















Continued-Fig. 6.2: The PDZ binding motif is critical for the interaction of NR2c 
with SNX27. (C), HEK293T cells were co-transfected with the indicated Myc-tagged 
NR2c-CT (aa1066-1236) (or Myc-tagged NR2c-CTΔSEV (aa1066-1233)) and HA-
tagged SNX27aFL (or one of its deletion mutants). 24 hr after transfection, total cell 
lysates were prepared and incubated with anti-Myc cross-linked agarose beads. The 
immunoprecipitates were resolved by electrophoresis, transferred to nitrocellulose, 
and probed with rabbit polyclonal antibody against the HA tag (upper panel) to detect 
the efficiency of co-immunoprecipitation as a measure of interaction. Following 
stripping, the Western blot was re-probed with rabbit polyclonal antibody against the 
Myc tag (middle panel) to ensure that immunoprecipitation of the Myc-tagged 
proteins was effective. 5% of the lysates used in the immunoprecipitations was also 
resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit 
polyclonal antibody against the HA tag (lower panel) to show the expression of 











6.4 SNX27 co-localizes with NR2c in rat hippocampal neurons 
NMDARs are found at both synaptic and extrasynaptic sites, but are present at a much 
higher density at the synapse (Tovar and Westbrook, 1999). If SNX27 regulates the 
trafficking of NMDAR in neurons, then we would expect to find some NR2c and 
SNX27 being present in the same compartment. We next examined whether SNX27 is 
targeted to sub-cellular compartments containing NR2c in hippocampal neurons. 
Primary cultured mouse hippocampal neurons were co-transfected with Myc-NR2cFL 
and HA-SNX27aFL, then immunostained for Myc-NR2c or HA-tagged SNX27a (Fig. 
6.3). Comparison of SNX27 puncta with NR2c puncta showed numerous regions of 
overlap (Fig. 6.3), as well as other regions of non-overlap. Thus, these results indicate 
that some SNX27 is targeted to the sub-regions of neuron that contain NR2c. 
6.5 Increased NR2c expression in the SNX27-/- mice brains 
Given the neuronal distribution of endosomal SNX27 described here, we hypothesize 
that SNX27 may participate in the intracellular trafficking of NR2c. We have 
therefore examined whether the NR2c expression level is altered in the SNX27-/- mice. 
Newborn SNX27-/- and wild-type pups from same litter were sacrificed and the brains 
were pooled and homogenized in RIPA buffer in the presence of complete EDTA-free 
protease inhibitor mixture. The lysate was centrifuged at 16.0 X103 g for 30 min at 
4oC and the supernatant was collected, equal amounts of total proteins were analyzed 
by Western blot (Fig. 6.4A). The NR2c expression levels were elevated about 40% in 





















Fig. 6.3: SNX27 is partially overlapped with NR2c in primary cultured 
neurons. Primary cultured neurons were Co-transfected with HA-SNX27aFL 
and Myc-NR2cFL. Myc-NR2c and HA-SNX27a were revealed by indirect 
immunofluorescence microscopy. Co-localizations of the Myc-NR2c and HA-
SNX27a were indicated in the merged image. Bar: 10 µm. 
Fig. 6.4: The increased NR2c expression levels in SNX27-/- mice. (A), 
SNX27 deficiency altered the expression levels of NR2c. Equal amount of total 
proteins from newborn pups’ brain lysates were analyzed by Western blot to 
detect NR2c levels in wild-type (+/+) and SNX27-/- (-/-) mice. (B), Results from 
four independent experiments exampled in A were quantitated by densitometric 
analysis. After being normalized against the level of β-actin, the average of the 
NR2c expression level was presented. The values of proteins in wild-type mice 
were set as 100%. Data shown are means ± SD. P<0.05. 





Yeast two-hybrid system is one of the most established and widely used techniques to 
find candidate interacting proteins. For example, SNX1 was identified through the 
yeast two-hybrid screening by using the kinase domain of EGFR as the bait (Kurten et 
al., 1996). However, this approach also brings a lot of non-specific bindings and junk 
proteins. Thus, the stringent verifications of each candidate, such as by GST pull 
down, immunoprecipitation, in vitro binding assay and so on, are required in order to 
verify the interaction after the screening.  
Through yeast two-hybrid screening, we identified several SNX27 interacting 
candidates. We have verified one of them, the NMDA Receptor 2c (NR2c). SNX27 
interacted with the C-terminal PDZ binding motif of NR2c via the PDZ domain. In 
addition, SNX27 was targeted to the sites marked by NR2c in hippocampal neurons. 
Our study suggests SNX27 is a potential candidate to influence the trafficking of the 
NMDA receptor complex and may also help to define the role of SNX27 in neuron. 
The NMDARs are glutamate-gated ion channel that mainly localized to the 
postsynaptic densities. The trafficking of NMDAR in neurons has been well studied 
during the last decade. The NMDA receptors together with its companion glutamate 
receptors, the AMPA receptors, have been shown to be added on and removed from 
the synapse based on activity, providing a possible molecular mechanism for long-
term potentiation (LTP) and long-term depression (LTD) (Malinow and Malenka, 
2002; Bredt and Nicoll, 2003; Wenthold et al., 2003). 
NMDARs are heteromeric complexes, consisting of one core NR1 and one or more 
NR2a-d subunits or possibly NR3 subunits. Newly synthesized NMDARs are 




preceded through the Golgi apparatus and finally inserted to the neuronal surface 
(Washbourne et al., 2002). SAP-102 and PSD-95, members of the membrane-
associated guanylate kinase (MAGUK) family, both contain three PDZ domains. 
They directly bind to the extreme C-terminal PDZ binding motif of NMDA receptors 
via PDZ domain and anchor NMDARs to the synaptic sites (Roche et al., 2001; Kim 
and Sheng, 2004).  
The surface expression of NMDA receptors, which represents a balance between 
receptor insertion and internalization, is tightly regulated (Roche et al., 2001). It has 
been reported that the NMDA receptor internalization is mediated by clathrin-
dependent endocytosis (Roche et al., 2001; Scott et al., 2004). The NR1 and NR2 
cytosolic domains contain both tyrosine (YXXΦ) and dileucine (LL) motifs that bind 
to AP-2 adaptors and link internalizing NMDAR complex to clathrin-mediated 
endocytosis. However, the tyrosine-based internalization motif “YEKL” at the C-
terminus of NR2b is the strongest consensus internalization motifs (Roche et al., 2001; 
Scott et al., 2004). Thus, the surface NMDA receptors at regions lacking PSD-95 
might be modulated by rapid receptor internalization (Roche et al., 2001).  
Among all PX domain proteins, SNX27 is the only one that contains the PDZ domain 
(Xu et al., 2001b; Seet and Hong, 2006; Cullen, 2008). Recent studies have 
demonstrated SNX27 interacts with some class I PDZ binding motif containing 
proteins and mediates their endosomal trafficking. For example, SNX27 interacts with 
5-HT4a (5-hydro-xytryptamine 4a) receptor at the early endosomes and modulates the 
trafficking of this receptor (Joubert et al., 2004). Similar effect on Kir3 channels was 
reported by Slesinger’s laboratory. SNX27 was found to reduce surface expression of 
Kir3.2c in cells co-expressing Kir3.3 and SNX27 (Lunn et al., 2007). This effect has 




Surface NMDARs are endocytosed through clathrin-coated vesicles and delivered 
into the sorting endosome and finally the late endosome/lysosome for degradation 
(Scott et al., 2004). Based on our results, the NR2c expression level was increased in 
the SNX27-/- mouse brains. It could be envisioned that the interaction between SNX27 
and the PDZ binding motif of NR2c may facilitate the sorting of NR2c to the late 
endosome/lysosome for degradation. Depletion of SNX27 will thus inhibit lysosomal 
targeting and degradation, leading to increased NR2c levels in the SNX27-/- brains. 
The detailed molecular and cellular mechanism remains to be established by future 
study. Collectively, these results suggest that SNX27 interacts with NR2c via the PDZ 
















             CHAPTER 7: CONCLUSIONS AND FUTURE PERSPECTIVES 
The research works described in this thesis attempt to characterize the biochemical 
and cell biological properties of SNX27 as well as to define its physiological roles. 
The results are summarized below: 
1. SNX27 preferentially binds to PI(3)P through the PX domain. SNX27 is targeted 
to the early endosome via the PX domain in a PI 3-kinase dependent manner.  
2. The depletion of SNX27 in A431 cells inhibited the EGF-induced EGFR 
endocytosis and degradation, although SNX27 did not directly interact with EGFR. 
3. Novel interaction of SNX27 with NR2c has been identified through the yeast two-
hybrid assays. The interaction is mediated by the SNX27-PDZ domain and the C-
terminal PDZ binding motif “SEV” of NR2c.  
4. A SNX27-/- mouse line has been generated. SNX27 protein is not expressed in the 
SNX27-/- mice as assessed by immunolabeling and Western blot analysis. The 
SNX27-/- mice displayed severe postnatal growth retardation as compared with their 
wild-type littermates and all SNX27-/- mice died by the age of weaning under normal 
condition, but postnatal survival can be prolonged to 4-6 weeks after reducing milk 
competition. 
5. SNX27-/- mice showed reduced sizes of various organs. The kidney displayed 
delayed nephron maturation and postnatal medulla degeneration.  
6. The urine chemistry analysis of one-month-old SNX27-/- mice revealed highly 
increased osmolality and proteinuria. These lesions are accompanied by upregulation 




reabsorption may contribute to the increased osmolality and protein content of 
SNX27-/- mice urine.  
7. Histological analysis revealed defects in the testis and brains in some SNX27-/- 
mice, although further analysis is needed to gain more understanding. 
From the cell biological study, I have demonstrated that interaction of PX domain of 
SNX27 with PI(3)P (phosphatidylinositol-3-phosphate) mediates targeting of SNX27 
to the early endosome, which is consistent with several recent reports (Joubert et al., 
2004; Lunn et al., 2007; Rincon et al., 2007). It is clear that the binding of 
phosphatidylinositol to the PX domain of sorting nexins is a key step in their 
membrane association for cargo sorting (Worby and Dixon, 2002; Seet and Hong, 
2006; Cullen, 2008). Furthermore, by using SNX27-specific antibodies, the 
endogenous SNX27 was shown to be widely expressed in tissue cultured cells and 
various mouse tissues, suggesting that SNX27 may play a general role in endocytic 
trafficking.  
To date, a few SNX27 interacting proteins have been identified, including cytohesin 
associated scaffolding protein (CASP), 5HT4a receptor, diacylglycerol kinase δ 
(DAKδ) and potassium channel 3, all of which contain a class I PDZ binding motif 
(MacNeil et al., 2007; Joubert et al., 2004; Rincon et al., 2007; Lunn et al., 2007). 
The demonstration of the interaction of SNX27 with NR2c is potentially interesting as 
this is the first sorting nexin identified to interact with a neurotransmitter receptor. 
The interaction of SNX27 with NMDAR suggests a previously unknown pathway for 
regulating NMDA receptor endocytosis by sorting nexins. Our challenge is to 




Collectively, the cellular, biochemical and genetic studies of SNX27, a unique PDZ 
domain containing sorting nexin, established a molecular mechanism of SNX27 to 
interact with class I PDZ domain binding motif containing proteins and to regulate 
their endocytic trafficking (Fig. 7.1). 
 
Fig. 7.1: A working model of SNX27. SNX27 interacts with class I PDZ domain 
binding motif containing proteins via PDZ domain and facilitates their early 
endosomal targeting and sorting to the late endosome/lysosome.  
 
To facilitate functional study, we have generated SNX27 knockout mice and revealed 
that SNX27 plays an essential role in postnatal growth and survival. The structures of 
various tissues were not dramatically affected as shown by histological analysis, 
except for the kidney. As the kidney undergoes extensive postnatal growth and 




postnatal kidney development and kidney diseases. In this study, main renal lesions 
are localized at medullar area.  
The SNX27 knockout mice also provide a unique animal model to further prove 
hypothesis of SNX27 functions in regulating endocytic trafficking of various surface 
proteins. Since the PDZ domain of SNX27 may potentially interact with multiple 
proteins containing the PDZ-binding motif in the early endosome, SNX27 may 
participate in regulation of trafficking and function of many different proteins. 
Combined consequence of altered trafficking and functionality of multiple proteins in 
multiple organs may be the basis for the observed growth retardation and postnatal 
lethality. The availability of SNX27 knockout mice will greatly facilitate the scientific 
community to study the trafficking and functionality of specific SNX27-interacting 
proteins in various cell types and tissues. For example, the role of SNX27 in 
regulating endosomal sorting of Kir3.2c to the lysosome, revealed recently in cell 
based study (Lunn et al., 2007), is validated in vivo as the level of Kir3.2c is increased 
in SNX27-/- brain as absence of SNX27 is predicted to impair lysosomal targeting of 
Kir3.2c. The SNX27-/- mice and resulting cultured neurons in combination with 
rescuing experiments will allow more mechanistic and functional study of SNX27’s 
role in Kir3.2c trafficking. 
The identification of NR2c as an interacting protein of SNX27 and the demonstration 
that NR2c levels increased in the SNX27-/- mice suggest SNX27 may regulate 
endosomal sorting of NR2c for delivery to the late endosome/lysosome. To clearly 
address the effect of depletion SNX27 in the regulation of NMDAR internalization 
and endocytic sorting events, we should use surface biotinylation assay to quantify the 
ratio of internalized surface NMDA receptors under NMDA treatment in primary 




Taken together, my thesis works have clearly defined the basic biochemical and cell 
biological properties of SNX27 and shown that SNX27 is important for postnatal 
growth and survival. An essential role of SNX27 in postnatal development and 
maturation of the kidney was revealed, although the mechanism is yet to be defined.  
Future studies along these discoveries will offer more insightful understanding about 
the mechanism of SNX27 regulating of trafficking of various surface proteins, as well 
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1. Phosphate-Buffered Saline (PBS), pH 7.4  
 
Final concentration(for 1 liter)   
137 mM NaCl  8 g  
2.7 mM KCl  0.2 g  
10 mM Na2HPO4  1.44 g  
2 mM KH2PO4  0.24 g  
 
Top up with H2O to 1 liter. 
 
2. LB Medium (Luria Bertani Medium)  
 
For 1 liter:  
 
Trypone   10g  
Yeast extract   5g  
NaCl  10g 
 
Adjust the pH to 7.0 with 5M NaOH (~0.2 ml). 
 
 3. LB Agar 
  
Agar powder         15 g  
Sodium chloride          5 g  
Tryptone         10 g  
Yeast extract          5 g  
 
Top up to 1 liter with deionized water and adjust pH to ~7.0. Autoclave and pour 
about 25 ml per petri dish. 
 
4. Bacteria Freezing Medium  
 




5. Cell Freezing Solution  
 
















Stock solution/Liter  
TAE  1X  
40 mM Tris-
acetate  
1 mM EDTA  
50X  
242 g of Tris base  
57.1 ml of glacial acetic acid  
100 ml of 0.5 M EDTA (pH 
8.0)  
 
7. Agarose Gel Resolution  
 
% Gel  Optimum Resolution for Linear DNA (kb)  
0.5  30 to 1.0  
0.7  12 to 0.8  
1.0  10 to 0.5  
1.2  7 to 0.4  
1.5  3 to 0.2  
 
8. 6X DNA Gel-loading Buffers  
 
Buffer Type  6X Buffer (50 ml)  
I (for larger size DNA)  30% glycerol (15 ml of glycerol stock)  
0.3% bromophenol blue (0.15 g)  
1 mM EDTA (100 μl of 0.5 M EDTA, pH 
8.0)  
II(for small size DNA)  50% glycerol (25 ml of glycerol stock)  
0.25% xylene cyanol FF (0.125 g)  
 
 
9. Electrophoresis Buffer  
 
                          
 
1X Working concentration 5X Stock solution/Liter 
25 mM Tris-Cl  
250 mM glycine  
0.1% SDS  
15.1 g of Tris base  
94 g of glycine (electrophoresis 
grade)  



















11. Coating Glass Coverslips  
 
POLYLYSINE AND POLYORNITHINE  
 
Nearly all types of cells adhere to these polymers of basic amino acids. They are 
particularly useful for the culture of CNS neurons. The L- or D-isomers can be used 
for cell attachment, however, the D-isomer may be preferred because it is not subject 
to breakdown by proteases released by cells.  
 
a. Prepare polylysine or polyornithine (MW of 30,000 - 70,000) at 0.1-1 mg/ml in 
0.15 M borate buffer (pH 8.3). Filter sterilize.  
 
b. Add enough solution to pool over surface of sterile glass coverslip.  
 
c. Incubate 2-24 hours at room temperature.  
 
d. Aspirate solution and wash coverslips 3 times with media or PBS.  
 
e. Immediately add cell suspension or growth media.  
 
 
